BlackRock Global Allocation Fund

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, APO has a market cap of 76.57B. Regarding current trading prices, MDLOX is priced at $19.16, while APO trades at $133.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas APO's P/E ratio is 18.30. In terms of profitability, MDLOX's ROE is N/A, compared to APO's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to APO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGIIX has a market cap of 57.59B. Regarding current trading prices, MDLOX is priced at $19.16, while SGIIX trades at $72.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGIIX's P/E ratio is 17.62. In terms of profitability, MDLOX's ROE is N/A, compared to SGIIX's ROE of N/A. Regarding short-term risk, MDLOX and SGIIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FESGX has a market cap of 57.59B. Regarding current trading prices, MDLOX is priced at $19.16, while FESGX trades at $69.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FESGX's P/E ratio is 17.81. In terms of profitability, MDLOX's ROE is N/A, compared to FESGX's ROE of N/A. Regarding short-term risk, MDLOX and FESGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGENX has a market cap of 57.59B. Regarding current trading prices, MDLOX is priced at $19.16, while SGENX trades at $72.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGENX's P/E ratio is 17.82. In terms of profitability, MDLOX's ROE is N/A, compared to SGENX's ROE of N/A. Regarding short-term risk, MDLOX and SGENX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FEGRX has a market cap of 57.59B. Regarding current trading prices, MDLOX is priced at $19.16, while FEGRX trades at $73.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FEGRX's P/E ratio is 17.83. In terms of profitability, MDLOX's ROE is N/A, compared to FEGRX's ROE of N/A. Regarding short-term risk, MDLOX and FEGRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, APO-PA has a market cap of 40.78B. Regarding current trading prices, MDLOX is priced at $19.16, while APO-PA trades at $71.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas APO-PA's P/E ratio is 8.57. In terms of profitability, MDLOX's ROE is N/A, compared to APO-PA's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to APO-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GBLEX has a market cap of 25.67B. Regarding current trading prices, MDLOX is priced at $19.16, while GBLEX trades at $37.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GBLEX's P/E ratio is 19.60. In terms of profitability, MDLOX's ROE is N/A, compared to GBLEX's ROE of N/A. Regarding short-term risk, MDLOX and GBLEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AGVEX has a market cap of 15.32B. Regarding current trading prices, MDLOX is priced at $19.16, while AGVEX trades at $24.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AGVEX's P/E ratio is 24.42. In terms of profitability, MDLOX's ROE is N/A, compared to AGVEX's ROE of N/A. Regarding short-term risk, MDLOX and AGVEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FSGGX has a market cap of 11.37B. Regarding current trading prices, MDLOX is priced at $19.16, while FSGGX trades at $16.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FSGGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSGGX's ROE of N/A. Regarding short-term risk, MDLOX and FSGGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLFOX has a market cap of 9.16B. Regarding current trading prices, MDLOX is priced at $19.16, while GLFOX trades at $17.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLFOX's P/E ratio is 17.96. In terms of profitability, MDLOX's ROE is N/A, compared to GLFOX's ROE of N/A. Regarding short-term risk, MDLOX and GLFOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLIFX has a market cap of 9.16B. Regarding current trading prices, MDLOX is priced at $19.16, while GLIFX trades at $17.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLIFX's P/E ratio is 17.97. In terms of profitability, MDLOX's ROE is N/A, compared to GLIFX's ROE of N/A. Regarding short-term risk, MDLOX and GLIFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AAM-PA has a market cap of 8.76B. Regarding current trading prices, MDLOX is priced at $19.16, while AAM-PA trades at $25.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AAM-PA's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PA's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AAM-PB has a market cap of 8.76B. Regarding current trading prices, MDLOX is priced at $19.16, while AAM-PB trades at $25.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AAM-PB's P/E ratio is 40.26. In terms of profitability, MDLOX's ROE is N/A, compared to AAM-PB's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to AAM-PB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, QYLD has a market cap of 8.35B. Regarding current trading prices, MDLOX is priced at $19.16, while QYLD trades at $16.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas QYLD's P/E ratio is 29.71. In terms of profitability, MDLOX's ROE is N/A, compared to QYLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to QYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PAVE has a market cap of 7.65B. Regarding current trading prices, MDLOX is priced at $19.16, while PAVE trades at $39.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PAVE's P/E ratio is 22.79. In terms of profitability, MDLOX's ROE is N/A, compared to PAVE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PAVE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VHGEX has a market cap of 7.21B. Regarding current trading prices, MDLOX is priced at $19.16, while VHGEX trades at $35.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VHGEX's P/E ratio is 20.09. In terms of profitability, MDLOX's ROE is N/A, compared to VHGEX's ROE of +0.00%. Regarding short-term risk, MDLOX and VHGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DFGEX has a market cap of 6.97B. Regarding current trading prices, MDLOX is priced at $19.16, while DFGEX trades at $10.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DFGEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DFGEX's ROE of N/A. Regarding short-term risk, MDLOX and DFGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JATSX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JATSX trades at $55.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JATSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATSX's ROE of N/A. Regarding short-term risk, MDLOX and JATSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JATAX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JATAX trades at $57.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JATAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATAX's ROE of N/A. Regarding short-term risk, MDLOX and JATAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGTX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JAGTX trades at $59.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGTX's ROE of N/A. Regarding short-term risk, MDLOX and JAGTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGCX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JAGCX trades at $46.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGCX's ROE of N/A. Regarding short-term risk, MDLOX and JAGCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JATNX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JATNX trades at $60.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JATNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATNX's ROE of N/A. Regarding short-term risk, MDLOX and JATNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JATIX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JATIX trades at $61.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JATIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JATIX's ROE of N/A. Regarding short-term risk, MDLOX and JATIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JNGTX has a market cap of 6.42B. Regarding current trading prices, MDLOX is priced at $19.16, while JNGTX trades at $60.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JNGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGTX's ROE of N/A. Regarding short-term risk, MDLOX and JNGTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PAGSX has a market cap of 6.37B. Regarding current trading prices, MDLOX is priced at $19.16, while PAGSX trades at $61.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PAGSX's P/E ratio is 25.53. In terms of profitability, MDLOX's ROE is N/A, compared to PAGSX's ROE of N/A. Regarding short-term risk, MDLOX and PAGSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PRGSX has a market cap of 6.37B. Regarding current trading prices, MDLOX is priced at $19.16, while PRGSX trades at $62.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PRGSX's P/E ratio is 25.53. In terms of profitability, MDLOX's ROE is N/A, compared to PRGSX's ROE of N/A. Regarding short-term risk, MDLOX and PRGSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ACWV has a market cap of 6.09B. Regarding current trading prices, MDLOX is priced at $19.16, while ACWV trades at $118.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ACWV's P/E ratio is 19.84. In terms of profitability, MDLOX's ROE is N/A, compared to ACWV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ACWV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGGFX has a market cap of 5.81B. Regarding current trading prices, MDLOX is priced at $19.16, while PGGFX trades at $22.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGGFX's P/E ratio is 22.78. In terms of profitability, MDLOX's ROE is N/A, compared to PGGFX's ROE of N/A. Regarding short-term risk, MDLOX and PGGFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PRJQX has a market cap of 5.79B. Regarding current trading prices, MDLOX is priced at $19.16, while PRJQX trades at $44.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PRJQX's P/E ratio is 41.43. In terms of profitability, MDLOX's ROE is N/A, compared to PRJQX's ROE of N/A. Regarding short-term risk, MDLOX and PRJQX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PRJZX has a market cap of 5.79B. Regarding current trading prices, MDLOX is priced at $19.16, while PRJZX trades at $43.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PRJZX's P/E ratio is 41.42. In terms of profitability, MDLOX's ROE is N/A, compared to PRJZX's ROE of N/A. Regarding short-term risk, MDLOX and PRJZX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CGGO has a market cap of 5.10B. Regarding current trading prices, MDLOX is priced at $19.16, while CGGO trades at $29.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CGGO's P/E ratio is 23.54. In terms of profitability, MDLOX's ROE is N/A, compared to CGGO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CGGO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GUNR has a market cap of 4.85B. Regarding current trading prices, MDLOX is priced at $19.16, while GUNR trades at $37.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GUNR's P/E ratio is 15.64. In terms of profitability, MDLOX's ROE is N/A, compared to GUNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GUNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JDWNX has a market cap of 4.79B. Regarding current trading prices, MDLOX is priced at $19.16, while JDWNX trades at $110.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JDWNX's P/E ratio is 15.26. In terms of profitability, MDLOX's ROE is N/A, compared to JDWNX's ROE of N/A. Regarding short-term risk, MDLOX and JDWNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JFNAX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JFNAX trades at $66.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JFNAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNAX's ROE of N/A. Regarding short-term risk, MDLOX and JFNAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGLX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JAGLX trades at $67.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGLX's ROE of N/A. Regarding short-term risk, MDLOX and JAGLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JFNNX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JFNNX trades at $67.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JFNNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNNX's ROE of N/A. Regarding short-term risk, MDLOX and JFNNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JFNCX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JFNCX trades at $56.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JFNCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNCX's ROE of N/A. Regarding short-term risk, MDLOX and JFNCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JFNSX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JFNSX trades at $64.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JFNSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNSX's ROE of N/A. Regarding short-term risk, MDLOX and JFNSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JNGLX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JNGLX trades at $67.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JNGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JNGLX's ROE of N/A. Regarding short-term risk, MDLOX and JNGLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JFNIX has a market cap of 4.71B. Regarding current trading prices, MDLOX is priced at $19.16, while JFNIX trades at $68.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JFNIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JFNIX's ROE of N/A. Regarding short-term risk, MDLOX and JFNIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IOO has a market cap of 4.17B. Regarding current trading prices, MDLOX is priced at $19.16, while IOO trades at $97.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IOO's P/E ratio is 23.99. In terms of profitability, MDLOX's ROE is N/A, compared to IOO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IOO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PRGTX has a market cap of 3.97B. Regarding current trading prices, MDLOX is priced at $19.16, while PRGTX trades at $19.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PRGTX's P/E ratio is 35.97. In terms of profitability, MDLOX's ROE is N/A, compared to PRGTX's ROE of +0.05%. Regarding short-term risk, MDLOX and PRGTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JWGRX has a market cap of 3.91B. Regarding current trading prices, MDLOX is priced at $19.16, while JWGRX trades at $113.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JWGRX's P/E ratio is 2.96. In terms of profitability, MDLOX's ROE is N/A, compared to JWGRX's ROE of N/A. Regarding short-term risk, MDLOX and JWGRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, REET has a market cap of 3.78B. Regarding current trading prices, MDLOX is priced at $19.16, while REET trades at $24.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas REET's P/E ratio is 26.88. In terms of profitability, MDLOX's ROE is N/A, compared to REET's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to REET. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JDWRX has a market cap of 3.77B. Regarding current trading prices, MDLOX is priced at $19.16, while JDWRX trades at $111.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JDWRX's P/E ratio is 2.89. In terms of profitability, MDLOX's ROE is N/A, compared to JDWRX's ROE of N/A. Regarding short-term risk, MDLOX and JDWRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JWWFX has a market cap of 3.77B. Regarding current trading prices, MDLOX is priced at $19.16, while JWWFX trades at $113.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JWWFX's P/E ratio is 2.96. In terms of profitability, MDLOX's ROE is N/A, compared to JWWFX's ROE of N/A. Regarding short-term risk, MDLOX and JWWFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JWWCX has a market cap of 3.77B. Regarding current trading prices, MDLOX is priced at $19.16, while JWWCX trades at $107.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JWWCX's P/E ratio is 2.80. In terms of profitability, MDLOX's ROE is N/A, compared to JWWCX's ROE of N/A. Regarding short-term risk, MDLOX and JWWCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAWWX has a market cap of 3.77B. Regarding current trading prices, MDLOX is priced at $19.16, while JAWWX trades at $111.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAWWX's P/E ratio is 2.89. In terms of profitability, MDLOX's ROE is N/A, compared to JAWWX's ROE of N/A. Regarding short-term risk, MDLOX and JAWWX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JDWAX has a market cap of 3.77B. Regarding current trading prices, MDLOX is priced at $19.16, while JDWAX trades at $113.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JDWAX's P/E ratio is 2.94. In terms of profitability, MDLOX's ROE is N/A, compared to JDWAX's ROE of N/A. Regarding short-term risk, MDLOX and JDWAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CTYRX has a market cap of 3.66B. Regarding current trading prices, MDLOX is priced at $19.16, while CTYRX trades at $92.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CTYRX's P/E ratio is 37.78. In terms of profitability, MDLOX's ROE is N/A, compared to CTYRX's ROE of N/A. Regarding short-term risk, MDLOX and CTYRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DGSIX has a market cap of 3.58B. Regarding current trading prices, MDLOX is priced at $19.16, while DGSIX trades at $21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DGSIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DGSIX's ROE of N/A. Regarding short-term risk, MDLOX and DGSIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGHIX has a market cap of 3.41B. Regarding current trading prices, MDLOX is priced at $19.16, while BGHIX trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGHIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BGHIX's ROE of N/A. Regarding short-term risk, MDLOX and BGHIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VNQI has a market cap of 3.37B. Regarding current trading prices, MDLOX is priced at $19.16, while VNQI trades at $43.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VNQI's P/E ratio is 14.30. In terms of profitability, MDLOX's ROE is N/A, compared to VNQI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to VNQI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CTCAX has a market cap of 3.18B. Regarding current trading prices, MDLOX is priced at $19.16, while CTCAX trades at $80.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CTCAX's P/E ratio is 33.90. In terms of profitability, MDLOX's ROE is N/A, compared to CTCAX's ROE of N/A. Regarding short-term risk, MDLOX and CTCAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CTHCX has a market cap of 3.18B. Regarding current trading prices, MDLOX is priced at $19.16, while CTHCX trades at $67.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CTHCX's P/E ratio is 33.88. In terms of profitability, MDLOX's ROE is N/A, compared to CTHCX's ROE of N/A. Regarding short-term risk, MDLOX and CTHCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CTHRX has a market cap of 3.18B. Regarding current trading prices, MDLOX is priced at $19.16, while CTHRX trades at $87.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CTHRX's P/E ratio is 33.91. In terms of profitability, MDLOX's ROE is N/A, compared to CTHRX's ROE of N/A. Regarding short-term risk, MDLOX and CTHRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CMTFX has a market cap of 3.18B. Regarding current trading prices, MDLOX is priced at $19.16, while CMTFX trades at $85.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CMTFX's P/E ratio is 33.91. In terms of profitability, MDLOX's ROE is N/A, compared to CMTFX's ROE of N/A. Regarding short-term risk, MDLOX and CMTFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CGTUX has a market cap of 3.18B. Regarding current trading prices, MDLOX is priced at $19.16, while CGTUX trades at $87.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CGTUX's P/E ratio is 33.92. In terms of profitability, MDLOX's ROE is N/A, compared to CGTUX's ROE of N/A. Regarding short-term risk, MDLOX and CGTUX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IXJ has a market cap of 3.17B. Regarding current trading prices, MDLOX is priced at $19.16, while IXJ trades at $88.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IXJ's P/E ratio is 27.81. In terms of profitability, MDLOX's ROE is N/A, compared to IXJ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXJ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, XYLD has a market cap of 3.07B. Regarding current trading prices, MDLOX is priced at $19.16, while XYLD trades at $38.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas XYLD's P/E ratio is 24.28. In terms of profitability, MDLOX's ROE is N/A, compared to XYLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to XYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MGGIX has a market cap of 2.96B. Regarding current trading prices, MDLOX is priced at $19.16, while MGGIX trades at $37.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MGGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGIX's ROE of N/A. Regarding short-term risk, MDLOX and MGGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MGGPX has a market cap of 2.96B. Regarding current trading prices, MDLOX is priced at $19.16, while MGGPX trades at $34.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MGGPX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGGPX's ROE of N/A. Regarding short-term risk, MDLOX and MGGPX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MLPX has a market cap of 2.75B. Regarding current trading prices, MDLOX is priced at $19.16, while MLPX trades at $60.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MLPX's P/E ratio is 18.51. In terms of profitability, MDLOX's ROE is N/A, compared to MLPX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MLPX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LGMAX has a market cap of 2.74B. Regarding current trading prices, MDLOX is priced at $19.16, while LGMAX trades at $24.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LGMAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMAX's ROE of N/A. Regarding short-term risk, MDLOX and LGMAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LGMCX has a market cap of 2.74B. Regarding current trading prices, MDLOX is priced at $19.16, while LGMCX trades at $22.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LGMCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LGMCX's ROE of N/A. Regarding short-term risk, MDLOX and LGMCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LSWWX has a market cap of 2.74B. Regarding current trading prices, MDLOX is priced at $19.16, while LSWWX trades at $24.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LSWWX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LSWWX's ROE of N/A. Regarding short-term risk, MDLOX and LSWWX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MSFBX has a market cap of 2.71B. Regarding current trading prices, MDLOX is priced at $19.16, while MSFBX trades at $34.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MSFBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFBX's ROE of +0.42%. Regarding short-term risk, MDLOX and MSFBX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MSFLX has a market cap of 2.71B. Regarding current trading prices, MDLOX is priced at $19.16, while MSFLX trades at $33.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MSFLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSFLX's ROE of N/A. Regarding short-term risk, MDLOX and MSFLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GNR has a market cap of 2.70B. Regarding current trading prices, MDLOX is priced at $19.16, while GNR trades at $51.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GNR's P/E ratio is 15.71. In terms of profitability, MDLOX's ROE is N/A, compared to GNR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GNR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, URA has a market cap of 2.61B. Regarding current trading prices, MDLOX is priced at $19.16, while URA trades at $25.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas URA's P/E ratio is 20.08. In terms of profitability, MDLOX's ROE is N/A, compared to URA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to URA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CCHRX has a market cap of 2.59B. Regarding current trading prices, MDLOX is priced at $19.16, while CCHRX trades at $87.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CCHRX's P/E ratio is 27.66. In terms of profitability, MDLOX's ROE is N/A, compared to CCHRX's ROE of N/A. Regarding short-term risk, MDLOX and CCHRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, COPX has a market cap of 2.56B. Regarding current trading prices, MDLOX is priced at $19.16, while COPX trades at $38.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas COPX's P/E ratio is 13.68. In terms of profitability, MDLOX's ROE is N/A, compared to COPX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to COPX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, APDGX has a market cap of 2.53B. Regarding current trading prices, MDLOX is priced at $19.16, while APDGX trades at $24.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas APDGX's P/E ratio is 18.86. In terms of profitability, MDLOX's ROE is N/A, compared to APDGX's ROE of N/A. Regarding short-term risk, MDLOX and APDGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ARTGX has a market cap of 2.53B. Regarding current trading prices, MDLOX is priced at $19.16, while ARTGX trades at $24.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ARTGX's P/E ratio is 18.85. In terms of profitability, MDLOX's ROE is N/A, compared to ARTGX's ROE of N/A. Regarding short-term risk, MDLOX and ARTGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, APHGX has a market cap of 2.53B. Regarding current trading prices, MDLOX is priced at $19.16, while APHGX trades at $24.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas APHGX's P/E ratio is 18.85. In terms of profitability, MDLOX's ROE is N/A, compared to APHGX's ROE of N/A. Regarding short-term risk, MDLOX and APHGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FTGC has a market cap of 2.51B. Regarding current trading prices, MDLOX is priced at $19.16, while FTGC trades at $24.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FTGC's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FTGC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FTGC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VGWLX has a market cap of 2.44B. Regarding current trading prices, MDLOX is priced at $19.16, while VGWLX trades at $25.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VGWLX's P/E ratio is 15.74. In terms of profitability, MDLOX's ROE is N/A, compared to VGWLX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VGWAX has a market cap of 2.44B. Regarding current trading prices, MDLOX is priced at $19.16, while VGWAX trades at $32.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VGWAX's P/E ratio is 15.74. In terms of profitability, MDLOX's ROE is N/A, compared to VGWAX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGWAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NFRA has a market cap of 2.40B. Regarding current trading prices, MDLOX is priced at $19.16, while NFRA trades at $59.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NFRA's P/E ratio is 18.63. In terms of profitability, MDLOX's ROE is N/A, compared to NFRA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to NFRA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BOTZ has a market cap of 2.36B. Regarding current trading prices, MDLOX is priced at $19.16, while BOTZ trades at $29.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BOTZ's P/E ratio is 30.91. In terms of profitability, MDLOX's ROE is N/A, compared to BOTZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BOTZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DFGR has a market cap of 2.34B. Regarding current trading prices, MDLOX is priced at $19.16, while DFGR trades at $26.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DFGR's P/E ratio is 27.14. In terms of profitability, MDLOX's ROE is N/A, compared to DFGR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DFGR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORIX has a market cap of 2.29B. Regarding current trading prices, MDLOX is priced at $19.16, while JORIX trades at $18.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORIX's P/E ratio is 2.35. In terms of profitability, MDLOX's ROE is N/A, compared to JORIX's ROE of N/A. Regarding short-term risk, MDLOX and JORIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OPGIX has a market cap of 2.29B. Regarding current trading prices, MDLOX is priced at $19.16, while OPGIX trades at $45.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OPGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OPGIX's ROE of N/A. Regarding short-term risk, MDLOX and OPGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORAX has a market cap of 2.28B. Regarding current trading prices, MDLOX is priced at $19.16, while JORAX trades at $18.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORAX's P/E ratio is 2.34. In terms of profitability, MDLOX's ROE is N/A, compared to JORAX's ROE of N/A. Regarding short-term risk, MDLOX and JORAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORFX has a market cap of 2.27B. Regarding current trading prices, MDLOX is priced at $19.16, while JORFX trades at $18.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORFX's P/E ratio is 2.33. In terms of profitability, MDLOX's ROE is N/A, compared to JORFX's ROE of N/A. Regarding short-term risk, MDLOX and JORFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORNX has a market cap of 2.27B. Regarding current trading prices, MDLOX is priced at $19.16, while JORNX trades at $18.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORNX's P/E ratio is 2.33. In terms of profitability, MDLOX's ROE is N/A, compared to JORNX's ROE of N/A. Regarding short-term risk, MDLOX and JORNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JSLNX has a market cap of 2.27B. Regarding current trading prices, MDLOX is priced at $19.16, while JSLNX trades at $18.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JSLNX's P/E ratio is 2.32. In terms of profitability, MDLOX's ROE is N/A, compared to JSLNX's ROE of N/A. Regarding short-term risk, MDLOX and JSLNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGTTX has a market cap of 2.24B. Regarding current trading prices, MDLOX is priced at $19.16, while SGTTX trades at $73.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGTTX's P/E ratio is 25.14. In terms of profitability, MDLOX's ROE is N/A, compared to SGTTX's ROE of N/A. Regarding short-term risk, MDLOX and SGTTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORRX has a market cap of 2.23B. Regarding current trading prices, MDLOX is priced at $19.16, while JORRX trades at $17.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORRX's P/E ratio is 2.28. In terms of profitability, MDLOX's ROE is N/A, compared to JORRX's ROE of N/A. Regarding short-term risk, MDLOX and JORRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PFFD has a market cap of 2.22B. Regarding current trading prices, MDLOX is priced at $19.16, while PFFD trades at $18.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PFFD's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PFFD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PFFD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GCOW has a market cap of 2.18B. Regarding current trading prices, MDLOX is priced at $19.16, while GCOW trades at $36.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GCOW's P/E ratio is 13.24. In terms of profitability, MDLOX's ROE is N/A, compared to GCOW's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to GCOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MWEFX has a market cap of 2.15B. Regarding current trading prices, MDLOX is priced at $19.16, while MWEFX trades at $44.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MWEFX's P/E ratio is 23.56. In terms of profitability, MDLOX's ROE is N/A, compared to MWEFX's ROE of N/A. Regarding short-term risk, MDLOX and MWEFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VMVFX has a market cap of 2.13B. Regarding current trading prices, MDLOX is priced at $19.16, while VMVFX trades at $16.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VMVFX's P/E ratio is 20.68. In terms of profitability, MDLOX's ROE is N/A, compared to VMVFX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMVFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VMNVX has a market cap of 2.13B. Regarding current trading prices, MDLOX is priced at $19.16, while VMNVX trades at $32.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VMNVX's P/E ratio is 20.68. In terms of profitability, MDLOX's ROE is N/A, compared to VMNVX's ROE of +0.00%. Regarding short-term risk, MDLOX and VMNVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JORCX has a market cap of 2.13B. Regarding current trading prices, MDLOX is priced at $19.16, while JORCX trades at $16.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JORCX's P/E ratio is 2.18. In terms of profitability, MDLOX's ROE is N/A, compared to JORCX's ROE of N/A. Regarding short-term risk, MDLOX and JORCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGRNX has a market cap of 2.10B. Regarding current trading prices, MDLOX is priced at $19.16, while PGRNX trades at $22.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGRNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PGRNX's ROE of N/A. Regarding short-term risk, MDLOX and PGRNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGINX has a market cap of 2.10B. Regarding current trading prices, MDLOX is priced at $19.16, while PGINX trades at $23.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGINX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PGINX's ROE of N/A. Regarding short-term risk, MDLOX and PGINX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BIALX has a market cap of 2.10B. Regarding current trading prices, MDLOX is priced at $19.16, while BIALX trades at $28.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BIALX's P/E ratio is 28.19. In terms of profitability, MDLOX's ROE is N/A, compared to BIALX's ROE of N/A. Regarding short-term risk, MDLOX and BIALX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CSGZX has a market cap of 2.06B. Regarding current trading prices, MDLOX is priced at $19.16, while CSGZX trades at $67.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CSGZX's P/E ratio is 23.55. In terms of profitability, MDLOX's ROE is N/A, compared to CSGZX's ROE of N/A. Regarding short-term risk, MDLOX and CSGZX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IILGX has a market cap of 2.02B. Regarding current trading prices, MDLOX is priced at $19.16, while IILGX trades at $27.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IILGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to IILGX's ROE of N/A. Regarding short-term risk, MDLOX and IILGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ARTRX has a market cap of 2.01B. Regarding current trading prices, MDLOX is priced at $19.16, while ARTRX trades at $31.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ARTRX's P/E ratio is 35.67. In terms of profitability, MDLOX's ROE is N/A, compared to ARTRX's ROE of N/A. Regarding short-term risk, MDLOX and ARTRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGTRX has a market cap of 1.96B. Regarding current trading prices, MDLOX is priced at $19.16, while SGTRX trades at $64.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGTRX's P/E ratio is 25.12. In terms of profitability, MDLOX's ROE is N/A, compared to SGTRX's ROE of N/A. Regarding short-term risk, MDLOX and SGTRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MLPA has a market cap of 1.86B. Regarding current trading prices, MDLOX is priced at $19.16, while MLPA trades at $48.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MLPA's P/E ratio is 13.43. In terms of profitability, MDLOX's ROE is N/A, compared to MLPA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MLPA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ATERX has a market cap of 1.85B. Regarding current trading prices, MDLOX is priced at $19.16, while ATERX trades at $149.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ATERX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ATERX's ROE of +0.07%. Regarding short-term risk, MDLOX and ATERX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, POSAX has a market cap of 1.71B. Regarding current trading prices, MDLOX is priced at $19.16, while POSAX trades at $8.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas POSAX's P/E ratio is 25.65. In terms of profitability, MDLOX's ROE is N/A, compared to POSAX's ROE of N/A. Regarding short-term risk, MDLOX and POSAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VGPMX has a market cap of 1.59B. Regarding current trading prices, MDLOX is priced at $19.16, while VGPMX trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VGPMX's P/E ratio is 13.90. In terms of profitability, MDLOX's ROE is N/A, compared to VGPMX's ROE of +0.00%. Regarding short-term risk, MDLOX and VGPMX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RYLD has a market cap of 1.38B. Regarding current trading prices, MDLOX is priced at $19.16, while RYLD trades at $14.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RYLD's P/E ratio is 15.88. In terms of profitability, MDLOX's ROE is N/A, compared to RYLD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RYLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VEIGX has a market cap of 1.33B. Regarding current trading prices, MDLOX is priced at $19.16, while VEIGX trades at $36.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VEIGX's P/E ratio is 23.08. In terms of profitability, MDLOX's ROE is N/A, compared to VEIGX's ROE of +0.00%. Regarding short-term risk, MDLOX and VEIGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VESGX has a market cap of 1.33B. Regarding current trading prices, MDLOX is priced at $19.16, while VESGX trades at $45.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VESGX's P/E ratio is 23.08. In terms of profitability, MDLOX's ROE is N/A, compared to VESGX's ROE of +0.00%. Regarding short-term risk, MDLOX and VESGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CLIP has a market cap of 1.32B. Regarding current trading prices, MDLOX is priced at $19.16, while CLIP trades at $100.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CLIP's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CLIP's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to CLIP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ICLN has a market cap of 1.30B. Regarding current trading prices, MDLOX is priced at $19.16, while ICLN trades at $11.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ICLN's P/E ratio is 14.91. In terms of profitability, MDLOX's ROE is N/A, compared to ICLN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ICLN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PZTRX has a market cap of 1.28B. Regarding current trading prices, MDLOX is priced at $19.16, while PZTRX trades at $5.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PZTRX's P/E ratio is 62.60. In terms of profitability, MDLOX's ROE is N/A, compared to PZTRX's ROE of N/A. Regarding short-term risk, MDLOX and PZTRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, THORX has a market cap of 1.27B. Regarding current trading prices, MDLOX is priced at $19.16, while THORX trades at $38.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas THORX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to THORX's ROE of N/A. Regarding short-term risk, MDLOX and THORX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, THOIX has a market cap of 1.27B. Regarding current trading prices, MDLOX is priced at $19.16, while THOIX trades at $39.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas THOIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to THOIX's ROE of N/A. Regarding short-term risk, MDLOX and THOIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, THOCX has a market cap of 1.27B. Regarding current trading prices, MDLOX is priced at $19.16, while THOCX trades at $37.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas THOCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to THOCX's ROE of N/A. Regarding short-term risk, MDLOX and THOCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SIL has a market cap of 1.24B. Regarding current trading prices, MDLOX is priced at $19.16, while SIL trades at $36.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SIL's P/E ratio is 25.31. In terms of profitability, MDLOX's ROE is N/A, compared to SIL's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to SIL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CSSPX has a market cap of 1.23B. Regarding current trading prices, MDLOX is priced at $19.16, while CSSPX trades at $53.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CSSPX's P/E ratio is 27.03. In terms of profitability, MDLOX's ROE is N/A, compared to CSSPX's ROE of N/A. Regarding short-term risk, MDLOX and CSSPX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SHTCX has a market cap of 1.18B. Regarding current trading prices, MDLOX is priced at $19.16, while SHTCX trades at $38.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SHTCX's P/E ratio is 25.11. In terms of profitability, MDLOX's ROE is N/A, compared to SHTCX's ROE of N/A. Regarding short-term risk, MDLOX and SHTCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SCGVX has a market cap of 1.10B. Regarding current trading prices, MDLOX is priced at $19.16, while SCGVX trades at $29.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SCGVX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SCGVX's ROE of N/A. Regarding short-term risk, MDLOX and SCGVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SCMGX has a market cap of 1.10B. Regarding current trading prices, MDLOX is priced at $19.16, while SCMGX trades at $30.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SCMGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SCMGX's ROE of N/A. Regarding short-term risk, MDLOX and SCMGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGTAX has a market cap of 1.10B. Regarding current trading prices, MDLOX is priced at $19.16, while PGTAX trades at $64.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGTAX's P/E ratio is 33.95. In terms of profitability, MDLOX's ROE is N/A, compared to PGTAX's ROE of N/A. Regarding short-term risk, MDLOX and PGTAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RWO has a market cap of 1.09B. Regarding current trading prices, MDLOX is priced at $19.16, while RWO trades at $44.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RWO's P/E ratio is 27.84. In terms of profitability, MDLOX's ROE is N/A, compared to RWO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RWO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OAKGX has a market cap of 1.07B. Regarding current trading prices, MDLOX is priced at $19.16, while OAKGX trades at $33.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OAKGX's P/E ratio is 14.80. In terms of profitability, MDLOX's ROE is N/A, compared to OAKGX's ROE of N/A. Regarding short-term risk, MDLOX and OAKGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PAGLX has a market cap of 1.02B. Regarding current trading prices, MDLOX is priced at $19.16, while PAGLX trades at $41.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PAGLX's P/E ratio is 22.66. In terms of profitability, MDLOX's ROE is N/A, compared to PAGLX's ROE of N/A. Regarding short-term risk, MDLOX and PAGLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RPGEX has a market cap of 1.02B. Regarding current trading prices, MDLOX is priced at $19.16, while RPGEX trades at $42.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RPGEX's P/E ratio is 22.67. In terms of profitability, MDLOX's ROE is N/A, compared to RPGEX's ROE of N/A. Regarding short-term risk, MDLOX and RPGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ROBO has a market cap of 1.02B. Regarding current trading prices, MDLOX is priced at $19.16, while ROBO trades at $52.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ROBO's P/E ratio is 23.93. In terms of profitability, MDLOX's ROE is N/A, compared to ROBO's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to ROBO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OAKWX has a market cap of 1.01B. Regarding current trading prices, MDLOX is priced at $19.16, while OAKWX trades at $24.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OAKWX's P/E ratio is 15.91. In terms of profitability, MDLOX's ROE is N/A, compared to OAKWX's ROE of N/A. Regarding short-term risk, MDLOX and OAKWX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JKG has a market cap of 991.76M. Regarding current trading prices, MDLOX is priced at $19.16, while JKG trades at $251.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JKG's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JKG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JKG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, QGRNX has a market cap of 989.47M. Regarding current trading prices, MDLOX is priced at $19.16, while QGRNX trades at $19.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas QGRNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to QGRNX's ROE of N/A. Regarding short-term risk, MDLOX and QGRNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, QGRCX has a market cap of 989.47M. Regarding current trading prices, MDLOX is priced at $19.16, while QGRCX trades at $18.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas QGRCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to QGRCX's ROE of N/A. Regarding short-term risk, MDLOX and QGRCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KXI has a market cap of 965.72M. Regarding current trading prices, MDLOX is priced at $19.16, while KXI trades at $66.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KXI's P/E ratio is 23.95. In terms of profitability, MDLOX's ROE is N/A, compared to KXI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KXI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EXI has a market cap of 945.71M. Regarding current trading prices, MDLOX is priced at $19.16, while EXI trades at $152.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EXI's P/E ratio is 22.37. In terms of profitability, MDLOX's ROE is N/A, compared to EXI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EXI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGEIX has a market cap of 943.02M. Regarding current trading prices, MDLOX is priced at $19.16, while BGEIX trades at $17.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGEIX's P/E ratio is 18.60. In terms of profitability, MDLOX's ROE is N/A, compared to BGEIX's ROE of N/A. Regarding short-term risk, MDLOX and BGEIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ARGT has a market cap of 941.94M. Regarding current trading prices, MDLOX is priced at $19.16, while ARGT trades at $83.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ARGT's P/E ratio is 11.89. In terms of profitability, MDLOX's ROE is N/A, compared to ARGT's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ARGT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ETW has a market cap of 885.16M. Regarding current trading prices, MDLOX is priced at $19.16, while ETW trades at $8.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ETW's P/E ratio is 8.15. In terms of profitability, MDLOX's ROE is N/A, compared to ETW's ROE of +0.15%. Regarding short-term risk, MDLOX is less volatile compared to ETW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESGYX has a market cap of 884.15M. Regarding current trading prices, MDLOX is priced at $19.16, while ESGYX trades at $20.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESGYX's P/E ratio is 27.98. In terms of profitability, MDLOX's ROE is N/A, compared to ESGYX's ROE of N/A. Regarding short-term risk, MDLOX and ESGYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESGMX has a market cap of 884.15M. Regarding current trading prices, MDLOX is priced at $19.16, while ESGMX trades at $19.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESGMX's P/E ratio is 27.95. In terms of profitability, MDLOX's ROE is N/A, compared to ESGMX's ROE of N/A. Regarding short-term risk, MDLOX and ESGMX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FFGCX has a market cap of 876.47M. Regarding current trading prices, MDLOX is priced at $19.16, while FFGCX trades at $18.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FFGCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FFGCX's ROE of +0.00%. Regarding short-term risk, MDLOX and FFGCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VCRAX has a market cap of 867.89M. Regarding current trading prices, MDLOX is priced at $19.16, while VCRAX trades at $14.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VCRAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to VCRAX's ROE of N/A. Regarding short-term risk, MDLOX and VCRAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TOLIX has a market cap of 861.47M. Regarding current trading prices, MDLOX is priced at $19.16, while TOLIX trades at $16.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TOLIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to TOLIX's ROE of N/A. Regarding short-term risk, MDLOX and TOLIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DGLCX has a market cap of 838.91M. Regarding current trading prices, MDLOX is priced at $19.16, while DGLCX trades at $17.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DGLCX's P/E ratio is 30.23. In terms of profitability, MDLOX's ROE is N/A, compared to DGLCX's ROE of N/A. Regarding short-term risk, MDLOX and DGLCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DGLAX has a market cap of 838.91M. Regarding current trading prices, MDLOX is priced at $19.16, while DGLAX trades at $19.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DGLAX's P/E ratio is 30.24. In terms of profitability, MDLOX's ROE is N/A, compared to DGLAX's ROE of N/A. Regarding short-term risk, MDLOX and DGLAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DGLRX has a market cap of 838.91M. Regarding current trading prices, MDLOX is priced at $19.16, while DGLRX trades at $20.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DGLRX's P/E ratio is 30.25. In terms of profitability, MDLOX's ROE is N/A, compared to DGLRX's ROE of N/A. Regarding short-term risk, MDLOX and DGLRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ARYVX has a market cap of 829.88M. Regarding current trading prices, MDLOX is priced at $19.16, while ARYVX trades at $13.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ARYVX's P/E ratio is 27.78. In terms of profitability, MDLOX's ROE is N/A, compared to ARYVX's ROE of +0.02%. Regarding short-term risk, MDLOX and ARYVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGLYX has a market cap of 788.43M. Regarding current trading prices, MDLOX is priced at $19.16, while SGLYX trades at $10.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGLYX's P/E ratio is 20.10. In terms of profitability, MDLOX's ROE is N/A, compared to SGLYX's ROE of N/A. Regarding short-term risk, MDLOX and SGLYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PORIX has a market cap of 774.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PORIX trades at $55.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PORIX's P/E ratio is 23.79. In terms of profitability, MDLOX's ROE is N/A, compared to PORIX's ROE of N/A. Regarding short-term risk, MDLOX and PORIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PORTX has a market cap of 774.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PORTX trades at $56.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PORTX's P/E ratio is 23.78. In terms of profitability, MDLOX's ROE is N/A, compared to PORTX's ROE of N/A. Regarding short-term risk, MDLOX and PORTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RPGAX has a market cap of 760.54M. Regarding current trading prices, MDLOX is priced at $19.16, while RPGAX trades at $15.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RPGAX's P/E ratio is 19.94. In terms of profitability, MDLOX's ROE is N/A, compared to RPGAX's ROE of N/A. Regarding short-term risk, MDLOX and RPGAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TEQAX has a market cap of 747.96M. Regarding current trading prices, MDLOX is priced at $19.16, while TEQAX trades at $27.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TEQAX's P/E ratio is 18.42. In terms of profitability, MDLOX's ROE is N/A, compared to TEQAX's ROE of N/A. Regarding short-term risk, MDLOX and TEQAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TROCX has a market cap of 747.96M. Regarding current trading prices, MDLOX is priced at $19.16, while TROCX trades at $29.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TROCX's P/E ratio is 18.42. In terms of profitability, MDLOX's ROE is N/A, compared to TROCX's ROE of N/A. Regarding short-term risk, MDLOX and TROCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JETS has a market cap of 744.02M. Regarding current trading prices, MDLOX is priced at $19.16, while JETS trades at $21.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JETS's P/E ratio is 10.71. In terms of profitability, MDLOX's ROE is N/A, compared to JETS's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JETS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MEGI has a market cap of 703.94M. Regarding current trading prices, MDLOX is priced at $19.16, while MEGI trades at $13.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MEGI's P/E ratio is 6.97. In terms of profitability, MDLOX's ROE is N/A, compared to MEGI's ROE of +0.02%. Regarding short-term risk, MDLOX is less volatile compared to MEGI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PXWEX has a market cap of 684.78M. Regarding current trading prices, MDLOX is priced at $19.16, while PXWEX trades at $32.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PXWEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PXWEX's ROE of N/A. Regarding short-term risk, MDLOX and PXWEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PXWIX has a market cap of 684.78M. Regarding current trading prices, MDLOX is priced at $19.16, while PXWIX trades at $32.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PXWIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PXWIX's ROE of N/A. Regarding short-term risk, MDLOX and PXWIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FOIIX has a market cap of 676.88M. Regarding current trading prices, MDLOX is priced at $19.16, while FOIIX trades at $31.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FOIIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FOIIX's ROE of N/A. Regarding short-term risk, MDLOX and FOIIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WFGGX has a market cap of 651.15M. Regarding current trading prices, MDLOX is priced at $19.16, while WFGGX trades at $27.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WFGGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WFGGX's ROE of N/A. Regarding short-term risk, MDLOX and WFGGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DIV has a market cap of 645.76M. Regarding current trading prices, MDLOX is priced at $19.16, while DIV trades at $17.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DIV's P/E ratio is 11.44. In terms of profitability, MDLOX's ROE is N/A, compared to DIV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DIV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FOOLX has a market cap of 637.41M. Regarding current trading prices, MDLOX is priced at $19.16, while FOOLX trades at $30.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FOOLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FOOLX's ROE of N/A. Regarding short-term risk, MDLOX and FOOLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BOE has a market cap of 623.29M. Regarding current trading prices, MDLOX is priced at $19.16, while BOE trades at $10.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BOE's P/E ratio is 10.72. In terms of profitability, MDLOX's ROE is N/A, compared to BOE's ROE of +0.09%. Regarding short-term risk, MDLOX is less volatile compared to BOE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IGLGX has a market cap of 601.45M. Regarding current trading prices, MDLOX is priced at $19.16, while IGLGX trades at $18.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IGLGX's P/E ratio is 30.18. In terms of profitability, MDLOX's ROE is N/A, compared to IGLGX's ROE of N/A. Regarding short-term risk, MDLOX and IGLGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TWGGX has a market cap of 598.27M. Regarding current trading prices, MDLOX is priced at $19.16, while TWGGX trades at $11.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TWGGX's P/E ratio is 30.40. In terms of profitability, MDLOX's ROE is N/A, compared to TWGGX's ROE of N/A. Regarding short-term risk, MDLOX and TWGGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FGD has a market cap of 593.46M. Regarding current trading prices, MDLOX is priced at $19.16, while FGD trades at $25.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FGD's P/E ratio is 9.46. In terms of profitability, MDLOX's ROE is N/A, compared to FGD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to FGD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KRMA has a market cap of 589.86M. Regarding current trading prices, MDLOX is priced at $19.16, while KRMA trades at $37.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KRMA's P/E ratio is 22.54. In terms of profitability, MDLOX's ROE is N/A, compared to KRMA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KRMA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NLGIX has a market cap of 578.09M. Regarding current trading prices, MDLOX is priced at $19.16, while NLGIX trades at $13.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NLGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to NLGIX's ROE of N/A. Regarding short-term risk, MDLOX and NLGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NGPAX has a market cap of 578.09M. Regarding current trading prices, MDLOX is priced at $19.16, while NGPAX trades at $13.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NGPAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to NGPAX's ROE of N/A. Regarding short-term risk, MDLOX and NGPAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IXG has a market cap of 569.36M. Regarding current trading prices, MDLOX is priced at $19.16, while IXG trades at $104.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IXG's P/E ratio is 14.15. In terms of profitability, MDLOX's ROE is N/A, compared to IXG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DGCB has a market cap of 549.62M. Regarding current trading prices, MDLOX is priced at $19.16, while DGCB trades at $52.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DGCB's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DGCB's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DGCB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HFAHF has a market cap of 543.99M. Regarding current trading prices, MDLOX is priced at $19.16, while HFAHF trades at $1.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HFAHF's P/E ratio is 3.47. In terms of profitability, MDLOX's ROE is N/A, compared to HFAHF's ROE of +0.20%. Regarding short-term risk, MDLOX and HFAHF have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLVNX has a market cap of 533.33M. Regarding current trading prices, MDLOX is priced at $19.16, while GLVNX trades at $74.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLVNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GLVNX's ROE of N/A. Regarding short-term risk, MDLOX and GLVNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLVAX has a market cap of 533.33M. Regarding current trading prices, MDLOX is priced at $19.16, while GLVAX trades at $78.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLVAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GLVAX's ROE of N/A. Regarding short-term risk, MDLOX and GLVAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HLMVX has a market cap of 519.34M. Regarding current trading prices, MDLOX is priced at $19.16, while HLMVX trades at $34.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HLMVX's P/E ratio is 27.71. In terms of profitability, MDLOX's ROE is N/A, compared to HLMVX's ROE of N/A. Regarding short-term risk, MDLOX and HLMVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HLMGX has a market cap of 519.34M. Regarding current trading prices, MDLOX is priced at $19.16, while HLMGX trades at $34.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HLMGX's P/E ratio is 27.70. In terms of profitability, MDLOX's ROE is N/A, compared to HLMGX's ROE of N/A. Regarding short-term risk, MDLOX and HLMGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GHY has a market cap of 517.85M. Regarding current trading prices, MDLOX is priced at $19.16, while GHY trades at $12.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GHY's P/E ratio is 8.01. In terms of profitability, MDLOX's ROE is N/A, compared to GHY's ROE of +0.13%. Regarding short-term risk, MDLOX is less volatile compared to GHY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CFWIX has a market cap of 513.35M. Regarding current trading prices, MDLOX is priced at $19.16, while CFWIX trades at $28.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CFWIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CFWIX's ROE of N/A. Regarding short-term risk, MDLOX and CFWIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CFWAX has a market cap of 513.35M. Regarding current trading prices, MDLOX is priced at $19.16, while CFWAX trades at $27.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CFWAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CFWAX's ROE of N/A. Regarding short-term risk, MDLOX and CFWAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CFWCX has a market cap of 513.35M. Regarding current trading prices, MDLOX is priced at $19.16, while CFWCX trades at $25.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CFWCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CFWCX's ROE of N/A. Regarding short-term risk, MDLOX and CFWCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGAIX has a market cap of 509.79M. Regarding current trading prices, MDLOX is priced at $19.16, while BGAIX trades at $38.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGAIX's P/E ratio is 41.17. In terms of profitability, MDLOX's ROE is N/A, compared to BGAIX's ROE of N/A. Regarding short-term risk, MDLOX and BGAIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGAFX has a market cap of 509.79M. Regarding current trading prices, MDLOX is priced at $19.16, while BGAFX trades at $37.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGAFX's P/E ratio is 41.16. In terms of profitability, MDLOX's ROE is N/A, compared to BGAFX's ROE of N/A. Regarding short-term risk, MDLOX and BGAFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGLUX has a market cap of 509.79M. Regarding current trading prices, MDLOX is priced at $19.16, while BGLUX trades at $38.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGLUX's P/E ratio is 41.17. In terms of profitability, MDLOX's ROE is N/A, compared to BGLUX's ROE of N/A. Regarding short-term risk, MDLOX and BGLUX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GII has a market cap of 498.62M. Regarding current trading prices, MDLOX is priced at $19.16, while GII trades at $64.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GII's P/E ratio is 19.88. In terms of profitability, MDLOX's ROE is N/A, compared to GII's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GII. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RGOIX has a market cap of 482.70M. Regarding current trading prices, MDLOX is priced at $19.16, while RGOIX trades at $20.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RGOIX's P/E ratio is 26.28. In terms of profitability, MDLOX's ROE is N/A, compared to RGOIX's ROE of N/A. Regarding short-term risk, MDLOX and RGOIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DNL has a market cap of 479.68M. Regarding current trading prices, MDLOX is priced at $19.16, while DNL trades at $37.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DNL's P/E ratio is 22.67. In terms of profitability, MDLOX's ROE is N/A, compared to DNL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DNL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MWOFX has a market cap of 469.50M. Regarding current trading prices, MDLOX is priced at $19.16, while MWOFX trades at $60.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MWOFX's P/E ratio is 26.90. In terms of profitability, MDLOX's ROE is N/A, compared to MWOFX's ROE of N/A. Regarding short-term risk, MDLOX and MWOFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RING has a market cap of 468.63M. Regarding current trading prices, MDLOX is priced at $19.16, while RING trades at $40.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RING's P/E ratio is 19.29. In terms of profitability, MDLOX's ROE is N/A, compared to RING's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RING. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ALTI has a market cap of 464.32M. Regarding current trading prices, MDLOX is priced at $19.16, while ALTI trades at $3.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ALTI's P/E ratio is -2.47. In terms of profitability, MDLOX's ROE is N/A, compared to ALTI's ROE of -0.17%. Regarding short-term risk, MDLOX is less volatile compared to ALTI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AUSF has a market cap of 464.11M. Regarding current trading prices, MDLOX is priced at $19.16, while AUSF trades at $42.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AUSF's P/E ratio is 14.88. In terms of profitability, MDLOX's ROE is N/A, compared to AUSF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to AUSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IGD has a market cap of 440.87M. Regarding current trading prices, MDLOX is priced at $19.16, while IGD trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IGD's P/E ratio is 7.08. In terms of profitability, MDLOX's ROE is N/A, compared to IGD's ROE of +0.13%. Regarding short-term risk, MDLOX is less volatile compared to IGD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MICGX has a market cap of 430.57M. Regarding current trading prices, MDLOX is priced at $19.16, while MICGX trades at $11.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MICGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MICGX's ROE of N/A. Regarding short-term risk, MDLOX and MICGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IXP has a market cap of 430.38M. Regarding current trading prices, MDLOX is priced at $19.16, while IXP trades at $101.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IXP's P/E ratio is 20.20. In terms of profitability, MDLOX's ROE is N/A, compared to IXP's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SMYIX has a market cap of 415.41M. Regarding current trading prices, MDLOX is priced at $19.16, while SMYIX trades at $24.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SMYIX's P/E ratio is 17.77. In terms of profitability, MDLOX's ROE is N/A, compared to SMYIX's ROE of +0.24%. Regarding short-term risk, MDLOX and SMYIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ETO has a market cap of 409.54M. Regarding current trading prices, MDLOX is priced at $19.16, while ETO trades at $24.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ETO's P/E ratio is 3.60. In terms of profitability, MDLOX's ROE is N/A, compared to ETO's ROE of +0.26%. Regarding short-term risk, MDLOX is less volatile compared to ETO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CSUAX has a market cap of 387.95M. Regarding current trading prices, MDLOX is priced at $19.16, while CSUAX trades at $24.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CSUAX's P/E ratio is 18.71. In terms of profitability, MDLOX's ROE is N/A, compared to CSUAX's ROE of N/A. Regarding short-term risk, MDLOX and CSUAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TMFG has a market cap of 377.03M. Regarding current trading prices, MDLOX is priced at $19.16, while TMFG trades at $29.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TMFG's P/E ratio is 30.13. In terms of profitability, MDLOX's ROE is N/A, compared to TMFG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to TMFG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CCGSX has a market cap of 373.01M. Regarding current trading prices, MDLOX is priced at $19.16, while CCGSX trades at $24.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CCGSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CCGSX's ROE of N/A. Regarding short-term risk, MDLOX and CCGSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CCGIX has a market cap of 373.01M. Regarding current trading prices, MDLOX is priced at $19.16, while CCGIX trades at $24.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CCGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CCGIX's ROE of N/A. Regarding short-term risk, MDLOX and CCGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MGLBX has a market cap of 353.71M. Regarding current trading prices, MDLOX is priced at $19.16, while MGLBX trades at $27.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MGLBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGLBX's ROE of N/A. Regarding short-term risk, MDLOX and MGLBX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGIIX has a market cap of 353.14M. Regarding current trading prices, MDLOX is priced at $19.16, while PGIIX trades at $25.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGIIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PGIIX's ROE of N/A. Regarding short-term risk, MDLOX and PGIIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGIRX has a market cap of 353.14M. Regarding current trading prices, MDLOX is priced at $19.16, while PGIRX trades at $24.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGIRX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PGIRX's ROE of N/A. Regarding short-term risk, MDLOX and PGIRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AWP has a market cap of 341.83M. Regarding current trading prices, MDLOX is priced at $19.16, while AWP trades at $3.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AWP's P/E ratio is 3.56. In terms of profitability, MDLOX's ROE is N/A, compared to AWP's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to AWP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PFFV has a market cap of 304.29M. Regarding current trading prices, MDLOX is priced at $19.16, while PFFV trades at $23.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PFFV's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PFFV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PFFV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DSHGX has a market cap of 299.17M. Regarding current trading prices, MDLOX is priced at $19.16, while DSHGX trades at $21.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DSHGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DSHGX's ROE of N/A. Regarding short-term risk, MDLOX and DSHGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DRIV has a market cap of 294.31M. Regarding current trading prices, MDLOX is priced at $19.16, while DRIV trades at $21.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DRIV's P/E ratio is 11.85. In terms of profitability, MDLOX's ROE is N/A, compared to DRIV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DRIV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GINNX has a market cap of 292.17M. Regarding current trading prices, MDLOX is priced at $19.16, while GINNX trades at $56.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GINNX's P/E ratio is 30.74. In terms of profitability, MDLOX's ROE is N/A, compared to GINNX's ROE of N/A. Regarding short-term risk, MDLOX and GINNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGH has a market cap of 289.53M. Regarding current trading prices, MDLOX is priced at $19.16, while BGH trades at $14.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGH's P/E ratio is 6.87. In terms of profitability, MDLOX's ROE is N/A, compared to BGH's ROE of +0.13%. Regarding short-term risk, MDLOX is less volatile compared to BGH. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IWIRX has a market cap of 285.59M. Regarding current trading prices, MDLOX is priced at $19.16, while IWIRX trades at $55.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IWIRX's P/E ratio is 30.74. In terms of profitability, MDLOX's ROE is N/A, compared to IWIRX's ROE of N/A. Regarding short-term risk, MDLOX and IWIRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MGU has a market cap of 280.76M. Regarding current trading prices, MDLOX is priced at $19.16, while MGU trades at $22.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MGU's P/E ratio is 5.55. In terms of profitability, MDLOX's ROE is N/A, compared to MGU's ROE of +0.15%. Regarding short-term risk, MDLOX is less volatile compared to MGU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FSBBX has a market cap of 277.76M. Regarding current trading prices, MDLOX is priced at $19.16, while FSBBX trades at $17.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FSBBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSBBX's ROE of N/A. Regarding short-term risk, MDLOX and FSBBX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FSBCX has a market cap of 264.37M. Regarding current trading prices, MDLOX is priced at $19.16, while FSBCX trades at $19.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FSBCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSBCX's ROE of N/A. Regarding short-term risk, MDLOX and FSBCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SBFIX has a market cap of 264.37M. Regarding current trading prices, MDLOX is priced at $19.16, while SBFIX trades at $20.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SBFIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SBFIX's ROE of N/A. Regarding short-term risk, MDLOX and SBFIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FSTBX has a market cap of 264.37M. Regarding current trading prices, MDLOX is priced at $19.16, while FSTBX trades at $20.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FSTBX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSTBX's ROE of N/A. Regarding short-term risk, MDLOX and FSTBX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FSBKX has a market cap of 264.37M. Regarding current trading prices, MDLOX is priced at $19.16, while FSBKX trades at $20.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FSBKX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FSBKX's ROE of N/A. Regarding short-term risk, MDLOX and FSBKX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WWOIX has a market cap of 263.01M. Regarding current trading prices, MDLOX is priced at $19.16, while WWOIX trades at $16.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WWOIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WWOIX's ROE of N/A. Regarding short-term risk, MDLOX and WWOIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NWWOX has a market cap of 263.01M. Regarding current trading prices, MDLOX is priced at $19.16, while NWWOX trades at $16.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NWWOX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to NWWOX's ROE of N/A. Regarding short-term risk, MDLOX and NWWOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FINX has a market cap of 260.27M. Regarding current trading prices, MDLOX is priced at $19.16, while FINX trades at $28.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FINX's P/E ratio is 27.44. In terms of profitability, MDLOX's ROE is N/A, compared to FINX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FINX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HGXAX has a market cap of 258.23M. Regarding current trading prices, MDLOX is priced at $19.16, while HGXAX trades at $15.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HGXAX's P/E ratio is 20.55. In terms of profitability, MDLOX's ROE is N/A, compared to HGXAX's ROE of N/A. Regarding short-term risk, MDLOX and HGXAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HGXYX has a market cap of 258.23M. Regarding current trading prices, MDLOX is priced at $19.16, while HGXYX trades at $15.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HGXYX's P/E ratio is 20.55. In terms of profitability, MDLOX's ROE is N/A, compared to HGXYX's ROE of N/A. Regarding short-term risk, MDLOX and HGXYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RXI has a market cap of 256.08M. Regarding current trading prices, MDLOX is priced at $19.16, while RXI trades at $180.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RXI's P/E ratio is 19.77. In terms of profitability, MDLOX's ROE is N/A, compared to RXI's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to RXI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AGD has a market cap of 253.25M. Regarding current trading prices, MDLOX is priced at $19.16, while AGD trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AGD's P/E ratio is 4.67. In terms of profitability, MDLOX's ROE is N/A, compared to AGD's ROE of +0.20%. Regarding short-term risk, MDLOX is less volatile compared to AGD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PSP has a market cap of 248.25M. Regarding current trading prices, MDLOX is priced at $19.16, while PSP trades at $64.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PSP's P/E ratio is 14.89. In terms of profitability, MDLOX's ROE is N/A, compared to PSP's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PSP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VSTKF has a market cap of 246.89M. Regarding current trading prices, MDLOX is priced at $19.16, while VSTKF trades at $1.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VSTKF's P/E ratio is -2.48. In terms of profitability, MDLOX's ROE is N/A, compared to VSTKF's ROE of -0.17%. Regarding short-term risk, MDLOX is less volatile compared to VSTKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GAL has a market cap of 243.18M. Regarding current trading prices, MDLOX is priced at $19.16, while GAL trades at $45.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GAL's P/E ratio is 17.33. In terms of profitability, MDLOX's ROE is N/A, compared to GAL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GAL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BPGIX has a market cap of 241.52M. Regarding current trading prices, MDLOX is priced at $19.16, while BPGIX trades at $25.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BPGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BPGIX's ROE of N/A. Regarding short-term risk, MDLOX and BPGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGAPX has a market cap of 238.27M. Regarding current trading prices, MDLOX is priced at $19.16, while SGAPX trades at $22.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGAPX's P/E ratio is 31.99. In terms of profitability, MDLOX's ROE is N/A, compared to SGAPX's ROE of +0.05%. Regarding short-term risk, MDLOX and SGAPX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SGACX has a market cap of 238.27M. Regarding current trading prices, MDLOX is priced at $19.16, while SGACX trades at $19.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SGACX's P/E ratio is 31.96. In terms of profitability, MDLOX's ROE is N/A, compared to SGACX's ROE of N/A. Regarding short-term risk, MDLOX and SGACX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CLSAX has a market cap of 235.50M. Regarding current trading prices, MDLOX is priced at $19.16, while CLSAX trades at $12.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CLSAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CLSAX's ROE of N/A. Regarding short-term risk, MDLOX and CLSAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WOOD has a market cap of 233.82M. Regarding current trading prices, MDLOX is priced at $19.16, while WOOD trades at $72.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WOOD's P/E ratio is 14.75. In terms of profitability, MDLOX's ROE is N/A, compared to WOOD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to WOOD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MXI has a market cap of 229.16M. Regarding current trading prices, MDLOX is priced at $19.16, while MXI trades at $83.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MXI's P/E ratio is 19.65. In terms of profitability, MDLOX's ROE is N/A, compared to MXI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MXI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PSAIX has a market cap of 225.61M. Regarding current trading prices, MDLOX is priced at $19.16, while PSAIX trades at $10.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PSAIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PSAIX's ROE of N/A. Regarding short-term risk, MDLOX and PSAIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JGCIX has a market cap of 224.87M. Regarding current trading prices, MDLOX is priced at $19.16, while JGCIX trades at $13.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JGCIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JGCIX's ROE of N/A. Regarding short-term risk, MDLOX and JGCIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JGCCX has a market cap of 224.87M. Regarding current trading prices, MDLOX is priced at $19.16, while JGCCX trades at $12.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JGCCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JGCCX's ROE of N/A. Regarding short-term risk, MDLOX and JGCCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JSPGX has a market cap of 224.87M. Regarding current trading prices, MDLOX is priced at $19.16, while JSPGX trades at $13.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JSPGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JSPGX's ROE of N/A. Regarding short-term risk, MDLOX and JSPGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JGCAX has a market cap of 224.87M. Regarding current trading prices, MDLOX is priced at $19.16, while JGCAX trades at $13.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JGCAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JGCAX's ROE of N/A. Regarding short-term risk, MDLOX and JGCAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JGCSX has a market cap of 224.87M. Regarding current trading prices, MDLOX is priced at $19.16, while JGCSX trades at $12.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JGCSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JGCSX's ROE of N/A. Regarding short-term risk, MDLOX and JGCSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, APFDX has a market cap of 223.31M. Regarding current trading prices, MDLOX is priced at $19.16, while APFDX trades at $21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas APFDX's P/E ratio is 40.48. In terms of profitability, MDLOX's ROE is N/A, compared to APFDX's ROE of N/A. Regarding short-term risk, MDLOX and APFDX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EOD has a market cap of 219.42M. Regarding current trading prices, MDLOX is priced at $19.16, while EOD trades at $5.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EOD's P/E ratio is 3.54. In terms of profitability, MDLOX's ROE is N/A, compared to EOD's ROE of +0.27%. Regarding short-term risk, MDLOX is less volatile compared to EOD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLO has a market cap of 214.52M. Regarding current trading prices, MDLOX is priced at $19.16, while GLO trades at $5.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLO's P/E ratio is 3.44. In terms of profitability, MDLOX's ROE is N/A, compared to GLO's ROE of +0.26%. Regarding short-term risk, MDLOX is less volatile compared to GLO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JSTC has a market cap of 212.29M. Regarding current trading prices, MDLOX is priced at $19.16, while JSTC trades at $18.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JSTC's P/E ratio is 22.16. In terms of profitability, MDLOX's ROE is N/A, compared to JSTC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JSTC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SNSR has a market cap of 204.40M. Regarding current trading prices, MDLOX is priced at $19.16, while SNSR trades at $33.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SNSR's P/E ratio is 25.67. In terms of profitability, MDLOX's ROE is N/A, compared to SNSR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SNSR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DAX has a market cap of 202.46M. Regarding current trading prices, MDLOX is priced at $19.16, while DAX trades at $42.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DAX's P/E ratio is 19.43. In terms of profitability, MDLOX's ROE is N/A, compared to DAX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DAX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGLAX has a market cap of 199.63M. Regarding current trading prices, MDLOX is priced at $19.16, while BGLAX trades at $14.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGLAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BGLAX's ROE of N/A. Regarding short-term risk, MDLOX and BGLAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WIGOX has a market cap of 193.30M. Regarding current trading prices, MDLOX is priced at $19.16, while WIGOX trades at $4.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WIGOX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WIGOX's ROE of N/A. Regarding short-term risk, MDLOX and WIGOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WAGOX has a market cap of 193.30M. Regarding current trading prices, MDLOX is priced at $19.16, while WAGOX trades at $4.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WAGOX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WAGOX's ROE of N/A. Regarding short-term risk, MDLOX and WAGOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WDIV has a market cap of 192.52M. Regarding current trading prices, MDLOX is priced at $19.16, while WDIV trades at $67.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WDIV's P/E ratio is 12.46. In terms of profitability, MDLOX's ROE is N/A, compared to WDIV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to WDIV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HGLB has a market cap of 190.79M. Regarding current trading prices, MDLOX is priced at $19.16, while HGLB trades at $8.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HGLB's P/E ratio is 6.01. In terms of profitability, MDLOX's ROE is N/A, compared to HGLB's ROE of +0.13%. Regarding short-term risk, MDLOX is less volatile compared to HGLB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SRET has a market cap of 185.75M. Regarding current trading prices, MDLOX is priced at $19.16, while SRET trades at $20.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SRET's P/E ratio is 14.85. In terms of profitability, MDLOX's ROE is N/A, compared to SRET's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SRET. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JSPMX has a market cap of 183.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JSPMX trades at $12.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JSPMX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JSPMX's ROE of N/A. Regarding short-term risk, MDLOX and JSPMX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JMOCX has a market cap of 183.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JMOCX trades at $12.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JMOCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JMOCX's ROE of N/A. Regarding short-term risk, MDLOX and JMOCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JMOAX has a market cap of 183.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JMOAX trades at $12.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JMOAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JMOAX's ROE of N/A. Regarding short-term risk, MDLOX and JMOAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JMOSX has a market cap of 183.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JMOSX trades at $12.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JMOSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JMOSX's ROE of N/A. Regarding short-term risk, MDLOX and JMOSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JMOIX has a market cap of 183.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JMOIX trades at $12.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JMOIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JMOIX's ROE of N/A. Regarding short-term risk, MDLOX and JMOIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GREK has a market cap of 178.25M. Regarding current trading prices, MDLOX is priced at $19.16, while GREK trades at $50.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GREK's P/E ratio is 9.36. In terms of profitability, MDLOX's ROE is N/A, compared to GREK's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GREK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGGIX has a market cap of 177.38M. Regarding current trading prices, MDLOX is priced at $19.16, while GGGIX trades at $59.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GGGIX's ROE of N/A. Regarding short-term risk, MDLOX and GGGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGGAX has a market cap of 177.38M. Regarding current trading prices, MDLOX is priced at $19.16, while GGGAX trades at $57.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGGAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GGGAX's ROE of N/A. Regarding short-term risk, MDLOX and GGGAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BGRSX has a market cap of 177.34M. Regarding current trading prices, MDLOX is priced at $19.16, while BGRSX trades at $15.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BGRSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BGRSX's ROE of N/A. Regarding short-term risk, MDLOX and BGRSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IGA has a market cap of 176.62M. Regarding current trading prices, MDLOX is priced at $19.16, while IGA trades at $9.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IGA's P/E ratio is 6.83. In terms of profitability, MDLOX's ROE is N/A, compared to IGA's ROE of +0.14%. Regarding short-term risk, MDLOX is less volatile compared to IGA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KRBN has a market cap of 169.49M. Regarding current trading prices, MDLOX is priced at $19.16, while KRBN trades at $28.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KRBN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to KRBN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KRBN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FTEMX has a market cap of 169.04M. Regarding current trading prices, MDLOX is priced at $19.16, while FTEMX trades at $12.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FTEMX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FTEMX's ROE of +0.02%. Regarding short-term risk, MDLOX and FTEMX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DBISX has a market cap of 167.99M. Regarding current trading prices, MDLOX is priced at $19.16, while DBISX trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DBISX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DBISX's ROE of N/A. Regarding short-term risk, MDLOX and DBISX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JXI has a market cap of 162.07M. Regarding current trading prices, MDLOX is priced at $19.16, while JXI trades at $71.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JXI's P/E ratio is 17.54. In terms of profitability, MDLOX's ROE is N/A, compared to JXI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JXI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PCGG has a market cap of 159.14M. Regarding current trading prices, MDLOX is priced at $19.16, while PCGG trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PCGG's P/E ratio is 31.86. In terms of profitability, MDLOX's ROE is N/A, compared to PCGG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PCGG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, THNQ has a market cap of 157.33M. Regarding current trading prices, MDLOX is priced at $19.16, while THNQ trades at $46.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas THNQ's P/E ratio is 34.50. In terms of profitability, MDLOX's ROE is N/A, compared to THNQ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to THNQ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ARTHX has a market cap of 156.08M. Regarding current trading prices, MDLOX is priced at $19.16, while ARTHX trades at $21.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ARTHX's P/E ratio is 18.27. In terms of profitability, MDLOX's ROE is N/A, compared to ARTHX's ROE of +0.24%. Regarding short-term risk, MDLOX and ARTHX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RJA has a market cap of 154.70M. Regarding current trading prices, MDLOX is priced at $19.16, while RJA trades at $9.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RJA's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RJA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RJA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, YFSNX has a market cap of 148.06M. Regarding current trading prices, MDLOX is priced at $19.16, while YFSNX trades at $14.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas YFSNX's P/E ratio is 8.77. In terms of profitability, MDLOX's ROE is N/A, compared to YFSNX's ROE of N/A. Regarding short-term risk, MDLOX and YFSNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SPRE has a market cap of 147.61M. Regarding current trading prices, MDLOX is priced at $19.16, while SPRE trades at $19.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SPRE's P/E ratio is 33.06. In terms of profitability, MDLOX's ROE is N/A, compared to SPRE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SPRE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GPRIX has a market cap of 146.97M. Regarding current trading prices, MDLOX is priced at $19.16, while GPRIX trades at $15.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GPRIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GPRIX's ROE of N/A. Regarding short-term risk, MDLOX and GPRIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGUAX has a market cap of 145.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PGUAX trades at $15.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGUAX's P/E ratio is 21.16. In terms of profitability, MDLOX's ROE is N/A, compared to PGUAX's ROE of N/A. Regarding short-term risk, MDLOX and PGUAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGIUX has a market cap of 145.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PGIUX trades at $15.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGIUX's P/E ratio is 21.15. In terms of profitability, MDLOX's ROE is N/A, compared to PGIUX's ROE of N/A. Regarding short-term risk, MDLOX and PGIUX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGUCX has a market cap of 145.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PGUCX trades at $15.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGUCX's P/E ratio is 21.13. In terms of profitability, MDLOX's ROE is N/A, compared to PGUCX's ROE of N/A. Regarding short-term risk, MDLOX and PGUCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DVRAX has a market cap of 141.96M. Regarding current trading prices, MDLOX is priced at $19.16, while DVRAX trades at $13.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DVRAX's P/E ratio is 20.68. In terms of profitability, MDLOX's ROE is N/A, compared to DVRAX's ROE of N/A. Regarding short-term risk, MDLOX and DVRAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TRGVX has a market cap of 140.81M. Regarding current trading prices, MDLOX is priced at $19.16, while TRGVX trades at $17.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TRGVX's P/E ratio is 17.47. In terms of profitability, MDLOX's ROE is N/A, compared to TRGVX's ROE of N/A. Regarding short-term risk, MDLOX and TRGVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ERUS has a market cap of 135.85M. Regarding current trading prices, MDLOX is priced at $19.16, while ERUS trades at $8.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ERUS's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ERUS's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ERUS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RPGIX has a market cap of 134.78M. Regarding current trading prices, MDLOX is priced at $19.16, while RPGIX trades at $19.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RPGIX's P/E ratio is 22.96. In terms of profitability, MDLOX's ROE is N/A, compared to RPGIX's ROE of N/A. Regarding short-term risk, MDLOX and RPGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CLACX has a market cap of 134.64M. Regarding current trading prices, MDLOX is priced at $19.16, while CLACX trades at $10.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CLACX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CLACX's ROE of N/A. Regarding short-term risk, MDLOX and CLACX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JCACX has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while JCACX trades at $11.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JCACX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JCACX's ROE of N/A. Regarding short-term risk, MDLOX and JCACX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JSPCX has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while JSPCX trades at $11.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JSPCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JSPCX's ROE of N/A. Regarding short-term risk, MDLOX and JSPCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JCASX has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while JCASX trades at $11.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JCASX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JCASX's ROE of N/A. Regarding short-term risk, MDLOX and JCASX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JCAAX has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while JCAAX trades at $11.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JCAAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JCAAX's ROE of N/A. Regarding short-term risk, MDLOX and JCAAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JCAIX has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while JCAIX trades at $11.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JCAIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JCAIX's ROE of N/A. Regarding short-term risk, MDLOX and JCAIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FAN has a market cap of 130.65M. Regarding current trading prices, MDLOX is priced at $19.16, while FAN trades at $15.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FAN's P/E ratio is 17.08. In terms of profitability, MDLOX's ROE is N/A, compared to FAN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FAN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TOLZ has a market cap of 130.20M. Regarding current trading prices, MDLOX is priced at $19.16, while TOLZ trades at $53.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TOLZ's P/E ratio is 20.13. In terms of profitability, MDLOX's ROE is N/A, compared to TOLZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to TOLZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DJIA has a market cap of 125.44M. Regarding current trading prices, MDLOX is priced at $19.16, while DJIA trades at $21.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DJIA's P/E ratio is 22.24. In terms of profitability, MDLOX's ROE is N/A, compared to DJIA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DJIA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CAGEX has a market cap of 124.51M. Regarding current trading prices, MDLOX is priced at $19.16, while CAGEX trades at $16.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CAGEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CAGEX's ROE of N/A. Regarding short-term risk, MDLOX and CAGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLQ has a market cap of 121.47M. Regarding current trading prices, MDLOX is priced at $19.16, while GLQ trades at $6.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLQ's P/E ratio is 3.05. In terms of profitability, MDLOX's ROE is N/A, compared to GLQ's ROE of +0.28%. Regarding short-term risk, MDLOX is less volatile compared to GLQ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ONOF has a market cap of 119.47M. Regarding current trading prices, MDLOX is priced at $19.16, while ONOF trades at $31.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ONOF's P/E ratio is 24.26. In terms of profitability, MDLOX's ROE is N/A, compared to ONOF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ONOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EKGYX has a market cap of 117.12M. Regarding current trading prices, MDLOX is priced at $19.16, while EKGYX trades at $37.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EKGYX's P/E ratio is 9.86. In terms of profitability, MDLOX's ROE is N/A, compared to EKGYX's ROE of N/A. Regarding short-term risk, MDLOX and EKGYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EKGCX has a market cap of 117.12M. Regarding current trading prices, MDLOX is priced at $19.16, while EKGCX trades at $19.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EKGCX's P/E ratio is 9.86. In terms of profitability, MDLOX's ROE is N/A, compared to EKGCX's ROE of N/A. Regarding short-term risk, MDLOX and EKGCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EKGAX has a market cap of 117.12M. Regarding current trading prices, MDLOX is priced at $19.16, while EKGAX trades at $35.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EKGAX's P/E ratio is 9.86. In terms of profitability, MDLOX's ROE is N/A, compared to EKGAX's ROE of N/A. Regarding short-term risk, MDLOX and EKGAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EKGIX has a market cap of 117.12M. Regarding current trading prices, MDLOX is priced at $19.16, while EKGIX trades at $38.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EKGIX's P/E ratio is 9.86. In terms of profitability, MDLOX's ROE is N/A, compared to EKGIX's ROE of N/A. Regarding short-term risk, MDLOX and EKGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SLVP has a market cap of 116.51M. Regarding current trading prices, MDLOX is priced at $19.16, while SLVP trades at $16.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SLVP's P/E ratio is 31.48. In terms of profitability, MDLOX's ROE is N/A, compared to SLVP's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to SLVP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RBIN has a market cap of 115.99M. Regarding current trading prices, MDLOX is priced at $19.16, while RBIN trades at $24.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RBIN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RBIN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RBIN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SOCL has a market cap of 115.13M. Regarding current trading prices, MDLOX is priced at $19.16, while SOCL trades at $44.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SOCL's P/E ratio is 18.47. In terms of profitability, MDLOX's ROE is N/A, compared to SOCL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SOCL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MILN has a market cap of 113.55M. Regarding current trading prices, MDLOX is priced at $19.16, while MILN trades at $44.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MILN's P/E ratio is 28.23. In terms of profitability, MDLOX's ROE is N/A, compared to MILN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MILN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DVAL has a market cap of 110.64M. Regarding current trading prices, MDLOX is priced at $19.16, while DVAL trades at $13.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DVAL's P/E ratio is 15.20. In terms of profitability, MDLOX's ROE is N/A, compared to DVAL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DVAL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GOAU has a market cap of 110.56M. Regarding current trading prices, MDLOX is priced at $19.16, while GOAU trades at $26.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GOAU's P/E ratio is 23.66. In terms of profitability, MDLOX's ROE is N/A, compared to GOAU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GOAU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RJI has a market cap of 108.85M. Regarding current trading prices, MDLOX is priced at $19.16, while RJI trades at $8.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RJI's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RJI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RJI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GMOM has a market cap of 107.29M. Regarding current trading prices, MDLOX is priced at $19.16, while GMOM trades at $28.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GMOM's P/E ratio is 14.17. In terms of profitability, MDLOX's ROE is N/A, compared to GMOM's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to GMOM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ZJPN has a market cap of 106.67M. Regarding current trading prices, MDLOX is priced at $19.16, while ZJPN trades at $91.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ZJPN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ZJPN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ZJPN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CGO has a market cap of 105.38M. Regarding current trading prices, MDLOX is priced at $19.16, while CGO trades at $10.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CGO's P/E ratio is 2.95. In terms of profitability, MDLOX's ROE is N/A, compared to CGO's ROE of +0.32%. Regarding short-term risk, MDLOX is less volatile compared to CGO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLOF has a market cap of 102.88M. Regarding current trading prices, MDLOX is priced at $19.16, while GLOF trades at $44.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLOF's P/E ratio is 17.66. In terms of profitability, MDLOX's ROE is N/A, compared to GLOF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GLOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGIAX has a market cap of 101.85M. Regarding current trading prices, MDLOX is priced at $19.16, while GGIAX trades at $13.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGIAX's P/E ratio is 20.98. In terms of profitability, MDLOX's ROE is N/A, compared to GGIAX's ROE of N/A. Regarding short-term risk, MDLOX and GGIAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGZ has a market cap of 98.10M. Regarding current trading prices, MDLOX is priced at $19.16, while GGZ trades at $12.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGZ's P/E ratio is 13.52. In terms of profitability, MDLOX's ROE is N/A, compared to GGZ's ROE of +0.07%. Regarding short-term risk, MDLOX and GGZ have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VEGI has a market cap of 93.35M. Regarding current trading prices, MDLOX is priced at $19.16, while VEGI trades at $38.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VEGI's P/E ratio is 18.15. In terms of profitability, MDLOX's ROE is N/A, compared to VEGI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to VEGI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TQGEX has a market cap of 91.04M. Regarding current trading prices, MDLOX is priced at $19.16, while TQGEX trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TQGEX's P/E ratio is 20.40. In terms of profitability, MDLOX's ROE is N/A, compared to TQGEX's ROE of +0.05%. Regarding short-term risk, MDLOX and TQGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GXG has a market cap of 86.12M. Regarding current trading prices, MDLOX is priced at $19.16, while GXG trades at $27.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GXG's P/E ratio is 7.84. In terms of profitability, MDLOX's ROE is N/A, compared to GXG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GXG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GESIX has a market cap of 85.93M. Regarding current trading prices, MDLOX is priced at $19.16, while GESIX trades at $17.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GESIX's P/E ratio is 27.70. In terms of profitability, MDLOX's ROE is N/A, compared to GESIX's ROE of N/A. Regarding short-term risk, MDLOX and GESIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GESOX has a market cap of 85.93M. Regarding current trading prices, MDLOX is priced at $19.16, while GESOX trades at $17.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GESOX's P/E ratio is 27.70. In terms of profitability, MDLOX's ROE is N/A, compared to GESOX's ROE of N/A. Regarding short-term risk, MDLOX and GESOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GDO has a market cap of 85.87M. Regarding current trading prices, MDLOX is priced at $19.16, while GDO trades at $11.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GDO's P/E ratio is 6.64. In terms of profitability, MDLOX's ROE is N/A, compared to GDO's ROE of +0.22%. Regarding short-term risk, MDLOX is less volatile compared to GDO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGSOX has a market cap of 84.69M. Regarding current trading prices, MDLOX is priced at $19.16, while GGSOX trades at $15.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGSOX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GGSOX's ROE of N/A. Regarding short-term risk, MDLOX and GGSOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GGSYX has a market cap of 84.69M. Regarding current trading prices, MDLOX is priced at $19.16, while GGSYX trades at $15.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GGSYX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GGSYX's ROE of N/A. Regarding short-term risk, MDLOX and GGSYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESGG has a market cap of 84.58M. Regarding current trading prices, MDLOX is priced at $19.16, while ESGG trades at $173.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESGG's P/E ratio is 21.29. In terms of profitability, MDLOX's ROE is N/A, compared to ESGG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ESGG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LVAGX has a market cap of 78.41M. Regarding current trading prices, MDLOX is priced at $19.16, while LVAGX trades at $14.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LVAGX's P/E ratio is 11.95. In terms of profitability, MDLOX's ROE is N/A, compared to LVAGX's ROE of N/A. Regarding short-term risk, MDLOX and LVAGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VEOIX has a market cap of 74.24M. Regarding current trading prices, MDLOX is priced at $19.16, while VEOIX trades at $20.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VEOIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to VEOIX's ROE of +0.00%. Regarding short-term risk, MDLOX and VEOIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EBIZ has a market cap of 72.99M. Regarding current trading prices, MDLOX is priced at $19.16, while EBIZ trades at $28.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EBIZ's P/E ratio is 21.99. In terms of profitability, MDLOX's ROE is N/A, compared to EBIZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EBIZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CADIX has a market cap of 72.62M. Regarding current trading prices, MDLOX is priced at $19.16, while CADIX trades at $21.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CADIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CADIX's ROE of N/A. Regarding short-term risk, MDLOX and CADIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, COGRX has a market cap of 72.62M. Regarding current trading prices, MDLOX is priced at $19.16, while COGRX trades at $19.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas COGRX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to COGRX's ROE of N/A. Regarding short-term risk, MDLOX and COGRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLNAX has a market cap of 69.13M. Regarding current trading prices, MDLOX is priced at $19.16, while GLNAX trades at $22.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLNAX's P/E ratio is 15.91. In terms of profitability, MDLOX's ROE is N/A, compared to GLNAX's ROE of N/A. Regarding short-term risk, MDLOX and GLNAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RGT has a market cap of 68.89M. Regarding current trading prices, MDLOX is priced at $19.16, while RGT trades at $10.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RGT's P/E ratio is 8.02. In terms of profitability, MDLOX's ROE is N/A, compared to RGT's ROE of +0.09%. Regarding short-term risk, MDLOX is less volatile compared to RGT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PBD has a market cap of 67.66M. Regarding current trading prices, MDLOX is priced at $19.16, while PBD trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PBD's P/E ratio is 17.49. In terms of profitability, MDLOX's ROE is N/A, compared to PBD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PBD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VPN has a market cap of 64.16M. Regarding current trading prices, MDLOX is priced at $19.16, while VPN trades at $15.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VPN's P/E ratio is 32.80. In terms of profitability, MDLOX's ROE is N/A, compared to VPN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to VPN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WWWEX has a market cap of 63.53M. Regarding current trading prices, MDLOX is priced at $19.16, while WWWEX trades at $17.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WWWEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WWWEX's ROE of N/A. Regarding short-term risk, MDLOX and WWWEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ASEA has a market cap of 60.54M. Regarding current trading prices, MDLOX is priced at $19.16, while ASEA trades at $16.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ASEA's P/E ratio is 12.77. In terms of profitability, MDLOX's ROE is N/A, compared to ASEA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ASEA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LPEFX has a market cap of 60.11M. Regarding current trading prices, MDLOX is priced at $19.16, while LPEFX trades at $6.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LPEFX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LPEFX's ROE of +0.00%. Regarding short-term risk, MDLOX and LPEFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FRN has a market cap of 58.95M. Regarding current trading prices, MDLOX is priced at $19.16, while FRN trades at $14.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FRN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FRN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FRN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AGNG has a market cap of 58.24M. Regarding current trading prices, MDLOX is priced at $19.16, while AGNG trades at $31.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AGNG's P/E ratio is 31.01. In terms of profitability, MDLOX's ROE is N/A, compared to AGNG's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to AGNG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EEB has a market cap of 57.95M. Regarding current trading prices, MDLOX is priced at $19.16, while EEB trades at $39.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EEB's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EEB's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EEB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EBLU has a market cap of 57.88M. Regarding current trading prices, MDLOX is priced at $19.16, while EBLU trades at $50.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EBLU's P/E ratio is 32.54. In terms of profitability, MDLOX's ROE is N/A, compared to EBLU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EBLU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DRW has a market cap of 57.06M. Regarding current trading prices, MDLOX is priced at $19.16, while DRW trades at $22.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DRW's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DRW's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DRW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FGBFX has a market cap of 56.11M. Regarding current trading prices, MDLOX is priced at $19.16, while FGBFX trades at $7.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FGBFX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FGBFX's ROE of +0.00%. Regarding short-term risk, MDLOX and FGBFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MIGIX has a market cap of 55.98M. Regarding current trading prices, MDLOX is priced at $19.16, while MIGIX trades at $17.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MIGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MIGIX's ROE of N/A. Regarding short-term risk, MDLOX and MIGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MSPTX has a market cap of 55.98M. Regarding current trading prices, MDLOX is priced at $19.16, while MSPTX trades at $14.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MSPTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MSPTX's ROE of N/A. Regarding short-term risk, MDLOX and MSPTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MIGPX has a market cap of 55.98M. Regarding current trading prices, MDLOX is priced at $19.16, while MIGPX trades at $16.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MIGPX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MIGPX's ROE of N/A. Regarding short-term risk, MDLOX and MIGPX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AGAQX has a market cap of 55.96M. Regarding current trading prices, MDLOX is priced at $19.16, while AGAQX trades at $10.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AGAQX's P/E ratio is 12.80. In terms of profitability, MDLOX's ROE is N/A, compared to AGAQX's ROE of N/A. Regarding short-term risk, MDLOX and AGAQX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HTY has a market cap of 54.50M. Regarding current trading prices, MDLOX is priced at $19.16, while HTY trades at $4.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HTY's P/E ratio is 83.17. In terms of profitability, MDLOX's ROE is N/A, compared to HTY's ROE of +0.04%. Regarding short-term risk, MDLOX is less volatile compared to HTY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ISDX has a market cap of 54.43M. Regarding current trading prices, MDLOX is priced at $19.16, while ISDX trades at $26.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ISDX's P/E ratio is 21.83. In terms of profitability, MDLOX's ROE is N/A, compared to ISDX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ISDX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FILL has a market cap of 53.12M. Regarding current trading prices, MDLOX is priced at $19.16, while FILL trades at $22.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FILL's P/E ratio is 12.12. In terms of profitability, MDLOX's ROE is N/A, compared to FILL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FILL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OIL has a market cap of 53.06M. Regarding current trading prices, MDLOX is priced at $19.16, while OIL trades at $28.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OIL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OIL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to OIL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OBEGX has a market cap of 52.62M. Regarding current trading prices, MDLOX is priced at $19.16, while OBEGX trades at $28.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OBEGX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OBEGX's ROE of +0.10%. Regarding short-term risk, MDLOX and OBEGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ZCAN has a market cap of 51.90M. Regarding current trading prices, MDLOX is priced at $19.16, while ZCAN trades at $70.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ZCAN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ZCAN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ZCAN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GAA has a market cap of 51.85M. Regarding current trading prices, MDLOX is priced at $19.16, while GAA trades at $29.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GAA's P/E ratio is 10.70. In terms of profitability, MDLOX's ROE is N/A, compared to GAA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GAA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NORW has a market cap of 51.43M. Regarding current trading prices, MDLOX is priced at $19.16, while NORW trades at $27.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NORW's P/E ratio is 11.71. In terms of profitability, MDLOX's ROE is N/A, compared to NORW's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to NORW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GNOM has a market cap of 50.88M. Regarding current trading prices, MDLOX is priced at $19.16, while GNOM trades at $8.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GNOM's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GNOM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GNOM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AZAL has a market cap of 50.55M. Regarding current trading prices, MDLOX is priced at $19.16, while AZAL trades at $27.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AZAL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to AZAL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to AZAL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, XYLG has a market cap of 50.36M. Regarding current trading prices, MDLOX is priced at $19.16, while XYLG trades at $26.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas XYLG's P/E ratio is 24.60. In terms of profitability, MDLOX's ROE is N/A, compared to XYLG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to XYLG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AGLOX has a market cap of 50.04M. Regarding current trading prices, MDLOX is priced at $19.16, while AGLOX trades at $13.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AGLOX's P/E ratio is 13.40. In terms of profitability, MDLOX's ROE is N/A, compared to AGLOX's ROE of N/A. Regarding short-term risk, MDLOX and AGLOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WGGNX has a market cap of 47.99M. Regarding current trading prices, MDLOX is priced at $19.16, while WGGNX trades at $10.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WGGNX's P/E ratio is 28.38. In terms of profitability, MDLOX's ROE is N/A, compared to WGGNX's ROE of N/A. Regarding short-term risk, MDLOX and WGGNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MGQIX has a market cap of 47.74M. Regarding current trading prices, MDLOX is priced at $19.16, while MGQIX trades at $17.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MGQIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MGQIX's ROE of -0.24%. Regarding short-term risk, MDLOX and MGQIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CUT has a market cap of 47.47M. Regarding current trading prices, MDLOX is priced at $19.16, while CUT trades at $29.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CUT's P/E ratio is 18.11. In terms of profitability, MDLOX's ROE is N/A, compared to CUT's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CUT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EMBOX has a market cap of 44.94M. Regarding current trading prices, MDLOX is priced at $19.16, while EMBOX trades at $10.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EMBOX's P/E ratio is 12.03. In terms of profitability, MDLOX's ROE is N/A, compared to EMBOX's ROE of N/A. Regarding short-term risk, MDLOX and EMBOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGJZX has a market cap of 44.56M. Regarding current trading prices, MDLOX is priced at $19.16, while PGJZX trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGJZX's P/E ratio is 18.17. In terms of profitability, MDLOX's ROE is N/A, compared to PGJZX's ROE of N/A. Regarding short-term risk, MDLOX and PGJZX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GURU has a market cap of 44.36M. Regarding current trading prices, MDLOX is priced at $19.16, while GURU trades at $49.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GURU's P/E ratio is 21.16. In terms of profitability, MDLOX's ROE is N/A, compared to GURU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GURU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HTEC has a market cap of 43.87M. Regarding current trading prices, MDLOX is priced at $19.16, while HTEC trades at $27.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HTEC's P/E ratio is 30.33. In terms of profitability, MDLOX's ROE is N/A, compared to HTEC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to HTEC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EWSC has a market cap of 43.82M. Regarding current trading prices, MDLOX is priced at $19.16, while EWSC trades at $67.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EWSC's P/E ratio is 39.95. In terms of profitability, MDLOX's ROE is N/A, compared to EWSC's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to EWSC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AIAFX has a market cap of 41.69M. Regarding current trading prices, MDLOX is priced at $19.16, while AIAFX trades at $24.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AIAFX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to AIAFX's ROE of +0.10%. Regarding short-term risk, MDLOX and AIAFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HGGIX has a market cap of 40.83M. Regarding current trading prices, MDLOX is priced at $19.16, while HGGIX trades at $24.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HGGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HGGIX's ROE of +0.11%. Regarding short-term risk, MDLOX and HGGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HGGAX has a market cap of 40.83M. Regarding current trading prices, MDLOX is priced at $19.16, while HGGAX trades at $25.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HGGAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HGGAX's ROE of N/A. Regarding short-term risk, MDLOX and HGGAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HNGIX has a market cap of 40.83M. Regarding current trading prices, MDLOX is priced at $19.16, while HNGIX trades at $25.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HNGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HNGIX's ROE of N/A. Regarding short-term risk, MDLOX and HNGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DMRE has a market cap of 39.61M. Regarding current trading prices, MDLOX is priced at $19.16, while DMRE trades at $46.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DMRE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to DMRE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DMRE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LNGR has a market cap of 39.38M. Regarding current trading prices, MDLOX is priced at $19.16, while LNGR trades at $27.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LNGR's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LNGR's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to LNGR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JETAX has a market cap of 37.85M. Regarding current trading prices, MDLOX is priced at $19.16, while JETAX trades at $14.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JETAX's P/E ratio is 16.88. In terms of profitability, MDLOX's ROE is N/A, compared to JETAX's ROE of N/A. Regarding short-term risk, MDLOX and JETAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FCGIX has a market cap of 37.79M. Regarding current trading prices, MDLOX is priced at $19.16, while FCGIX trades at $19.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FCGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FCGIX's ROE of N/A. Regarding short-term risk, MDLOX and FCGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GXF has a market cap of 36.64M. Regarding current trading prices, MDLOX is priced at $19.16, while GXF trades at $32.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GXF's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GXF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GXF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PGLOX has a market cap of 36.61M. Regarding current trading prices, MDLOX is priced at $19.16, while PGLOX trades at $17.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PGLOX's P/E ratio is 29.96. In terms of profitability, MDLOX's ROE is N/A, compared to PGLOX's ROE of N/A. Regarding short-term risk, MDLOX and PGLOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FLFGX has a market cap of 36.54M. Regarding current trading prices, MDLOX is priced at $19.16, while FLFGX trades at $11.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FLFGX's P/E ratio is 19.54. In terms of profitability, MDLOX's ROE is N/A, compared to FLFGX's ROE of N/A. Regarding short-term risk, MDLOX and FLFGX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JPMF has a market cap of 36.49M. Regarding current trading prices, MDLOX is priced at $19.16, while JPMF trades at $20.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JPMF's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JPMF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JPMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGAX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JAGAX trades at $9.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGAX's ROE of N/A. Regarding short-term risk, MDLOX and JAGAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGNX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JAGNX trades at $10.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGNX's ROE of N/A. Regarding short-term risk, MDLOX and JAGNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAGSX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JAGSX trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAGSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAGSX's ROE of N/A. Regarding short-term risk, MDLOX and JAGSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JVGTX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JVGTX trades at $9.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JVGTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JVGTX's ROE of N/A. Regarding short-term risk, MDLOX and JVGTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JVGIX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JVGIX trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JVGIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JVGIX's ROE of N/A. Regarding short-term risk, MDLOX and JVGIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JAVCX has a market cap of 36.23M. Regarding current trading prices, MDLOX is priced at $19.16, while JAVCX trades at $9.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JAVCX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JAVCX's ROE of N/A. Regarding short-term risk, MDLOX and JAVCX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SDEM has a market cap of 35.72M. Regarding current trading prices, MDLOX is priced at $19.16, while SDEM trades at $26.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SDEM's P/E ratio is 8.43. In terms of profitability, MDLOX's ROE is N/A, compared to SDEM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SDEM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ENTIX has a market cap of 35.37M. Regarding current trading prices, MDLOX is priced at $19.16, while ENTIX trades at $16.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ENTIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ENTIX's ROE of N/A. Regarding short-term risk, MDLOX and ENTIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PQIN has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while PQIN trades at $49.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PQIN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to PQIN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PQIN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JEASX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JEASX trades at $16.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JEASX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JEASX's ROE of N/A. Regarding short-term risk, MDLOX and JEASX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JEUIX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JEUIX trades at $16.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JEUIX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JEUIX's ROE of N/A. Regarding short-term risk, MDLOX and JEUIX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JECTX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JECTX trades at $16.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JECTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JECTX's ROE of N/A. Regarding short-term risk, MDLOX and JECTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JESSX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JESSX trades at $16.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JESSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JESSX's ROE of N/A. Regarding short-term risk, MDLOX and JESSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JEGRX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JEGRX trades at $16.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JEGRX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JEGRX's ROE of N/A. Regarding short-term risk, MDLOX and JEGRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JETNX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JETNX trades at $16.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JETNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JETNX's ROE of N/A. Regarding short-term risk, MDLOX and JETNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JETTX has a market cap of 33.46M. Regarding current trading prices, MDLOX is priced at $19.16, while JETTX trades at $16.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JETTX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JETTX's ROE of N/A. Regarding short-term risk, MDLOX and JETTX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WTMVX has a market cap of 33.10M. Regarding current trading prices, MDLOX is priced at $19.16, while WTMVX trades at $11.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WTMVX's P/E ratio is 25.52. In terms of profitability, MDLOX's ROE is N/A, compared to WTMVX's ROE of N/A. Regarding short-term risk, MDLOX and WTMVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EUMV has a market cap of 32.90M. Regarding current trading prices, MDLOX is priced at $19.16, while EUMV trades at $25.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EUMV's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EUMV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EUMV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BOAT has a market cap of 32.64M. Regarding current trading prices, MDLOX is priced at $19.16, while BOAT trades at $27.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BOAT's P/E ratio is 3.98. In terms of profitability, MDLOX's ROE is N/A, compared to BOAT's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BOAT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, OLD has a market cap of 31.75M. Regarding current trading prices, MDLOX is priced at $19.16, while OLD trades at $29.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas OLD's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to OLD's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to OLD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MFQAX has a market cap of 31.03M. Regarding current trading prices, MDLOX is priced at $19.16, while MFQAX trades at $17.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MFQAX's P/E ratio is 24.46. In terms of profitability, MDLOX's ROE is N/A, compared to MFQAX's ROE of N/A. Regarding short-term risk, MDLOX and MFQAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JIDA has a market cap of 30.56M. Regarding current trading prices, MDLOX is priced at $19.16, while JIDA trades at $43.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JIDA's P/E ratio is 11.97. In terms of profitability, MDLOX's ROE is N/A, compared to JIDA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JIDA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ZDEU has a market cap of 29.52M. Regarding current trading prices, MDLOX is priced at $19.16, while ZDEU trades at $67.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ZDEU's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ZDEU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ZDEU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GENY has a market cap of 29.51M. Regarding current trading prices, MDLOX is priced at $19.16, while GENY trades at $39.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GENY's P/E ratio is 14.86. In terms of profitability, MDLOX's ROE is N/A, compared to GENY's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GENY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LVL has a market cap of 29.23M. Regarding current trading prices, MDLOX is priced at $19.16, while LVL trades at $12.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LVL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to LVL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to LVL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GROW has a market cap of 28.44M. Regarding current trading prices, MDLOX is priced at $19.16, while GROW trades at $2.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GROW's P/E ratio is 53.25. In terms of profitability, MDLOX's ROE is N/A, compared to GROW's ROE of +0.01%. Regarding short-term risk, MDLOX is less volatile compared to GROW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NRES has a market cap of 28.36M. Regarding current trading prices, MDLOX is priced at $19.16, while NRES trades at $23.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NRES's P/E ratio is 16.09. In terms of profitability, MDLOX's ROE is N/A, compared to NRES's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to NRES. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PAK has a market cap of 28.08M. Regarding current trading prices, MDLOX is priced at $19.16, while PAK trades at $16.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PAK's P/E ratio is 4.92. In terms of profitability, MDLOX's ROE is N/A, compared to PAK's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PAK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RYFSX has a market cap of 27.97M. Regarding current trading prices, MDLOX is priced at $19.16, while RYFSX trades at $5.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RYFSX's P/E ratio is 8.18. In terms of profitability, MDLOX's ROE is N/A, compared to RYFSX's ROE of N/A. Regarding short-term risk, MDLOX and RYFSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RLTAX has a market cap of 27.81M. Regarding current trading prices, MDLOX is priced at $19.16, while RLTAX trades at $14.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RLTAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RLTAX's ROE of N/A. Regarding short-term risk, MDLOX and RLTAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CLOAX has a market cap of 26.91M. Regarding current trading prices, MDLOX is priced at $19.16, while CLOAX trades at $8.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CLOAX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CLOAX's ROE of N/A. Regarding short-term risk, MDLOX and CLOAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KOCG has a market cap of 26.06M. Regarding current trading prices, MDLOX is priced at $19.16, while KOCG trades at $28.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KOCG's P/E ratio is 20.80. In terms of profitability, MDLOX's ROE is N/A, compared to KOCG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KOCG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HYDR has a market cap of 25.99M. Regarding current trading prices, MDLOX is priced at $19.16, while HYDR trades at $16.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HYDR's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HYDR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to HYDR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AZTD has a market cap of 25.79M. Regarding current trading prices, MDLOX is priced at $19.16, while AZTD trades at $24.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AZTD's P/E ratio is 13.01. In terms of profitability, MDLOX's ROE is N/A, compared to AZTD's ROE of +0.00%. Regarding short-term risk, MDLOX and AZTD have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CTEC has a market cap of 25.64M. Regarding current trading prices, MDLOX is priced at $19.16, while CTEC trades at $5.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CTEC's P/E ratio is 15.73. In terms of profitability, MDLOX's ROE is N/A, compared to CTEC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CTEC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JPED has a market cap of 25.50M. Regarding current trading prices, MDLOX is priced at $19.16, while JPED trades at $21.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JPED's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JPED's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JPED. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FFR has a market cap of 24.87M. Regarding current trading prices, MDLOX is priced at $19.16, while FFR trades at $36.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FFR's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FFR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FFR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MKIEX has a market cap of 24.59M. Regarding current trading prices, MDLOX is priced at $19.16, while MKIEX trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MKIEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MKIEX's ROE of N/A. Regarding short-term risk, MDLOX and MKIEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MBEAX has a market cap of 24.58M. Regarding current trading prices, MDLOX is priced at $19.16, while MBEAX trades at $11.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MBEAX's P/E ratio is 19.84. In terms of profitability, MDLOX's ROE is N/A, compared to MBEAX's ROE of N/A. Regarding short-term risk, MDLOX and MBEAX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MBESX has a market cap of 24.58M. Regarding current trading prices, MDLOX is priced at $19.16, while MBESX trades at $11.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MBESX's P/E ratio is 19.90. In terms of profitability, MDLOX's ROE is N/A, compared to MBESX's ROE of N/A. Regarding short-term risk, MDLOX and MBESX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MBEYX has a market cap of 24.58M. Regarding current trading prices, MDLOX is priced at $19.16, while MBEYX trades at $11.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MBEYX's P/E ratio is 19.89. In terms of profitability, MDLOX's ROE is N/A, compared to MBEYX's ROE of N/A. Regarding short-term risk, MDLOX and MBEYX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NDIA has a market cap of 24.40M. Regarding current trading prices, MDLOX is priced at $19.16, while NDIA trades at $29.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NDIA's P/E ratio is 23.46. In terms of profitability, MDLOX's ROE is N/A, compared to NDIA's ROE of N/A. Regarding short-term risk, MDLOX and NDIA have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IDY has a market cap of 24.39M. Regarding current trading prices, MDLOX is priced at $19.16, while IDY trades at $22.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IDY's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to IDY's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IDY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESGF has a market cap of 24.23M. Regarding current trading prices, MDLOX is priced at $19.16, while ESGF trades at $30.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESGF's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ESGF's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ESGF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BITS has a market cap of 23.26M. Regarding current trading prices, MDLOX is priced at $19.16, while BITS trades at $57.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BITS's P/E ratio is 12.28. In terms of profitability, MDLOX's ROE is N/A, compared to BITS's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BITS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CYB has a market cap of 23.00M. Regarding current trading prices, MDLOX is priced at $19.16, while CYB trades at $24.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CYB's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CYB's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CYB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JZRO has a market cap of 22.93M. Regarding current trading prices, MDLOX is priced at $19.16, while JZRO trades at $19.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JZRO's P/E ratio is 11.39. In terms of profitability, MDLOX's ROE is N/A, compared to JZRO's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JZRO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AXJL has a market cap of 22.72M. Regarding current trading prices, MDLOX is priced at $19.16, while AXJL trades at $56.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AXJL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to AXJL's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to AXJL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MUSQ has a market cap of 22.17M. Regarding current trading prices, MDLOX is priced at $19.16, while MUSQ trades at $25.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MUSQ's P/E ratio is 29.26. In terms of profitability, MDLOX's ROE is N/A, compared to MUSQ's ROE of N/A. Regarding short-term risk, MDLOX and MUSQ have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MMAVX has a market cap of 20.44M. Regarding current trading prices, MDLOX is priced at $19.16, while MMAVX trades at $13.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MMAVX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MMAVX's ROE of N/A. Regarding short-term risk, MDLOX and MMAVX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EGPT has a market cap of 20.41M. Regarding current trading prices, MDLOX is priced at $19.16, while EGPT trades at $21.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EGPT's P/E ratio is 8.53. In terms of profitability, MDLOX's ROE is N/A, compared to EGPT's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EGPT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CEFA has a market cap of 20.23M. Regarding current trading prices, MDLOX is priced at $19.16, while CEFA trades at $33.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CEFA's P/E ratio is 15.90. In terms of profitability, MDLOX's ROE is N/A, compared to CEFA's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to CEFA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CHIX has a market cap of 19.77M. Regarding current trading prices, MDLOX is priced at $19.16, while CHIX trades at $10.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CHIX's P/E ratio is 4.60. In terms of profitability, MDLOX's ROE is N/A, compared to CHIX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CHIX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RNDM has a market cap of 19.59M. Regarding current trading prices, MDLOX is priced at $19.16, while RNDM trades at $50.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RNDM's P/E ratio is 15.53. In terms of profitability, MDLOX's ROE is N/A, compared to RNDM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RNDM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DXGE has a market cap of 19.23M. Regarding current trading prices, MDLOX is priced at $19.16, while DXGE trades at $33.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DXGE's P/E ratio is 8.83. In terms of profitability, MDLOX's ROE is N/A, compared to DXGE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DXGE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JJN has a market cap of 18.39M. Regarding current trading prices, MDLOX is priced at $19.16, while JJN trades at $28.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JJN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JJN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JJN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JPMV has a market cap of 18.26M. Regarding current trading prices, MDLOX is priced at $19.16, while JPMV trades at $60.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JPMV's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JPMV's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JPMV. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TGMEX has a market cap of 18.13M. Regarding current trading prices, MDLOX is priced at $19.16, while TGMEX trades at $8.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TGMEX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to TGMEX's ROE of +0.12%. Regarding short-term risk, MDLOX and TGMEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WMCNX has a market cap of 17.65M. Regarding current trading prices, MDLOX is priced at $19.16, while WMCNX trades at $10.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WMCNX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WMCNX's ROE of +0.02%. Regarding short-term risk, MDLOX and WMCNX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ISEM has a market cap of 17.58M. Regarding current trading prices, MDLOX is priced at $19.16, while ISEM trades at $23.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ISEM's P/E ratio is 6.98. In terms of profitability, MDLOX's ROE is N/A, compared to ISEM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ISEM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TTTN has a market cap of 16.68M. Regarding current trading prices, MDLOX is priced at $19.16, while TTTN trades at $43.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TTTN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to TTTN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to TTTN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FFIRX has a market cap of 16.67M. Regarding current trading prices, MDLOX is priced at $19.16, while FFIRX trades at $11.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FFIRX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FFIRX's ROE of N/A. Regarding short-term risk, MDLOX and FFIRX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CNGLX has a market cap of 15.97M. Regarding current trading prices, MDLOX is priced at $19.16, while CNGLX trades at $19.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CNGLX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CNGLX's ROE of +0.02%. Regarding short-term risk, MDLOX and CNGLX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JPEU has a market cap of 15.92M. Regarding current trading prices, MDLOX is priced at $19.16, while JPEU trades at $52.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JPEU's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to JPEU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JPEU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MXDE has a market cap of 15.32M. Regarding current trading prices, MDLOX is priced at $19.16, while MXDE trades at $23.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MXDE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MXDE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MXDE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESGW has a market cap of 14.67M. Regarding current trading prices, MDLOX is priced at $19.16, while ESGW trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESGW's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ESGW's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ESGW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FLQE has a market cap of 14.11M. Regarding current trading prices, MDLOX is priced at $19.16, while FLQE trades at $23.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FLQE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to FLQE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FLQE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CHIL has a market cap of 14.07M. Regarding current trading prices, MDLOX is priced at $19.16, while CHIL trades at $33.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CHIL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CHIL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CHIL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WCHN has a market cap of 13.92M. Regarding current trading prices, MDLOX is priced at $19.16, while WCHN trades at $27.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WCHN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WCHN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to WCHN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WAGSX has a market cap of 13.22M. Regarding current trading prices, MDLOX is priced at $19.16, while WAGSX trades at $12.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WAGSX's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to WAGSX's ROE of -0.06%. Regarding short-term risk, MDLOX and WAGSX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, PEX has a market cap of 13.15M. Regarding current trading prices, MDLOX is priced at $19.16, while PEX trades at $26.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas PEX's P/E ratio is 10.99. In terms of profitability, MDLOX's ROE is N/A, compared to PEX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to PEX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SROI has a market cap of 13.00M. Regarding current trading prices, MDLOX is priced at $19.16, while SROI trades at $29.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SROI's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SROI's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SROI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, QGTA has a market cap of 12.90M. Regarding current trading prices, MDLOX is priced at $19.16, while QGTA trades at $23.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas QGTA's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to QGTA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to QGTA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SBUG has a market cap of 12.73M. Regarding current trading prices, MDLOX is priced at $19.16, while SBUG trades at $33.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SBUG's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SBUG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SBUG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KOIN has a market cap of 12.72M. Regarding current trading prices, MDLOX is priced at $19.16, while KOIN trades at $33.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KOIN's P/E ratio is 19.17. In terms of profitability, MDLOX's ROE is N/A, compared to KOIN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KOIN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HEWC has a market cap of 12.69M. Regarding current trading prices, MDLOX is priced at $19.16, while HEWC trades at $28.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HEWC's P/E ratio is 12.68. In terms of profitability, MDLOX's ROE is N/A, compared to HEWC's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to HEWC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ZHOK has a market cap of 12.49M. Regarding current trading prices, MDLOX is priced at $19.16, while ZHOK trades at $72.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ZHOK's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ZHOK's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ZHOK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EWEM has a market cap of 12.38M. Regarding current trading prices, MDLOX is priced at $19.16, while EWEM trades at $31.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EWEM's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EWEM's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to EWEM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, MVIN has a market cap of 12.22M. Regarding current trading prices, MDLOX is priced at $19.16, while MVIN trades at $41.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas MVIN's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to MVIN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to MVIN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GLCN has a market cap of 12.10M. Regarding current trading prices, MDLOX is priced at $19.16, while GLCN trades at $21.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GLCN's P/E ratio is 7.99. In terms of profitability, MDLOX's ROE is N/A, compared to GLCN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GLCN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BICK has a market cap of 12.06M. Regarding current trading prices, MDLOX is priced at $19.16, while BICK trades at $27.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BICK's P/E ratio is 12.10. In terms of profitability, MDLOX's ROE is N/A, compared to BICK's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to BICK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ADRU has a market cap of 11.86M. Regarding current trading prices, MDLOX is priced at $19.16, while ADRU trades at $21.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ADRU's P/E ratio is 253.76. In terms of profitability, MDLOX's ROE is N/A, compared to ADRU's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ADRU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, VNAM has a market cap of 11.41M. Regarding current trading prices, MDLOX is priced at $19.16, while VNAM trades at $15.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas VNAM's P/E ratio is 14.46. In terms of profitability, MDLOX's ROE is N/A, compared to VNAM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to VNAM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SLIM has a market cap of 11.34M. Regarding current trading prices, MDLOX is priced at $19.16, while SLIM trades at $33.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SLIM's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to SLIM's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to SLIM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GXTG has a market cap of 11.22M. Regarding current trading prices, MDLOX is priced at $19.16, while GXTG trades at $22.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GXTG's P/E ratio is 21.49. In terms of profitability, MDLOX's ROE is N/A, compared to GXTG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GXTG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LSTOX has a market cap of 11.11M. Regarding current trading prices, MDLOX is priced at $19.16, while LSTOX trades at $12.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LSTOX's P/E ratio is 26.86. In terms of profitability, MDLOX's ROE is N/A, compared to LSTOX's ROE of N/A. Regarding short-term risk, MDLOX and LSTOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ICOL has a market cap of 10.82M. Regarding current trading prices, MDLOX is priced at $19.16, while ICOL trades at $9.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ICOL's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ICOL's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ICOL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EVSTC has a market cap of 10.57M. Regarding current trading prices, MDLOX is priced at $19.16, while EVSTC trades at $99.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EVSTC's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EVSTC's ROE of +0.00%. Regarding short-term risk, MDLOX and EVSTC have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EVGBC has a market cap of 10.29M. Regarding current trading prices, MDLOX is priced at $19.16, while EVGBC trades at $99.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EVGBC's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EVGBC's ROE of N/A. Regarding short-term risk, MDLOX and EVGBC have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EAFD has a market cap of 10.25M. Regarding current trading prices, MDLOX is priced at $19.16, while EAFD trades at $17.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EAFD's P/E ratio is 11.68. In terms of profitability, MDLOX's ROE is N/A, compared to EAFD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EAFD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ACSG has a market cap of 10.06M. Regarding current trading prices, MDLOX is priced at $19.16, while ACSG trades at $33.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ACSG's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ACSG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ACSG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GAGEX has a market cap of 10.06M. Regarding current trading prices, MDLOX is priced at $19.16, while GAGEX trades at $21.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GAGEX's P/E ratio is 11.55. In terms of profitability, MDLOX's ROE is N/A, compared to GAGEX's ROE of N/A. Regarding short-term risk, MDLOX and GAGEX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TYLG has a market cap of 9.93M. Regarding current trading prices, MDLOX is priced at $19.16, while TYLG trades at $30.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TYLG's P/E ratio is 32.77. In terms of profitability, MDLOX's ROE is N/A, compared to TYLG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to TYLG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, AQWA has a market cap of 9.91M. Regarding current trading prices, MDLOX is priced at $19.16, while AQWA trades at $18.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas AQWA's P/E ratio is 23.42. In terms of profitability, MDLOX's ROE is N/A, compared to AQWA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to AQWA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EFAS has a market cap of 9.82M. Regarding current trading prices, MDLOX is priced at $19.16, while EFAS trades at $16.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EFAS's P/E ratio is 11.68. In terms of profitability, MDLOX's ROE is N/A, compared to EFAS's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EFAS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, INFR has a market cap of 9.67M. Regarding current trading prices, MDLOX is priced at $19.16, while INFR trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas INFR's P/E ratio is 19.43. In terms of profitability, MDLOX's ROE is N/A, compared to INFR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to INFR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CEZ has a market cap of 9.67M. Regarding current trading prices, MDLOX is priced at $19.16, while CEZ trades at $27.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CEZ's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CEZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CEZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, LVAFX has a market cap of 9.66M. Regarding current trading prices, MDLOX is priced at $19.16, while LVAFX trades at $10.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas LVAFX's P/E ratio is 12.51. In terms of profitability, MDLOX's ROE is N/A, compared to LVAFX's ROE of -0.02%. Regarding short-term risk, MDLOX and LVAFX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FLOW has a market cap of 9.60M. Regarding current trading prices, MDLOX is priced at $19.16, while FLOW trades at $29.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FLOW's P/E ratio is 13.06. In terms of profitability, MDLOX's ROE is N/A, compared to FLOW's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FLOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CHIK has a market cap of 9.37M. Regarding current trading prices, MDLOX is priced at $19.16, while CHIK trades at $13.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CHIK's P/E ratio is 10.12. In terms of profitability, MDLOX's ROE is N/A, compared to CHIK's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CHIK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BKES has a market cap of 9.33M. Regarding current trading prices, MDLOX is priced at $19.16, while BKES trades at $37.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BKES's P/E ratio is 22.38. In terms of profitability, MDLOX's ROE is N/A, compared to BKES's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BKES. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ESIFF has a market cap of 9.20M. Regarding current trading prices, MDLOX is priced at $19.16, while ESIFF trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ESIFF's P/E ratio is -14.36. In terms of profitability, MDLOX's ROE is N/A, compared to ESIFF's ROE of -0.89%. Regarding short-term risk, MDLOX and ESIFF have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GDMOX has a market cap of 9.19M. Regarding current trading prices, MDLOX is priced at $19.16, while GDMOX trades at $8.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GDMOX's P/E ratio is 16.18. In terms of profitability, MDLOX's ROE is N/A, compared to GDMOX's ROE of N/A. Regarding short-term risk, MDLOX and GDMOX have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, GIGE has a market cap of 9.03M. Regarding current trading prices, MDLOX is priced at $19.16, while GIGE trades at $17.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas GIGE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to GIGE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to GIGE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ERSX has a market cap of 9.02M. Regarding current trading prices, MDLOX is priced at $19.16, while ERSX trades at $11.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ERSX's P/E ratio is 10.80. In terms of profitability, MDLOX's ROE is N/A, compared to ERSX's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ERSX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BKIS has a market cap of 9.00M. Regarding current trading prices, MDLOX is priced at $19.16, while BKIS trades at $44.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BKIS's P/E ratio is 22.65. In terms of profitability, MDLOX's ROE is N/A, compared to BKIS's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BKIS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RFAP has a market cap of 8.79M. Regarding current trading prices, MDLOX is priced at $19.16, while RFAP trades at $58.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RFAP's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RFAP's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RFAP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, KROP has a market cap of 8.49M. Regarding current trading prices, MDLOX is priced at $19.16, while KROP trades at $10.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas KROP's P/E ratio is 19.97. In terms of profitability, MDLOX's ROE is N/A, compared to KROP's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to KROP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DBGR has a market cap of 8.45M. Regarding current trading prices, MDLOX is priced at $19.16, while DBGR trades at $34.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DBGR's P/E ratio is 14.23. In terms of profitability, MDLOX's ROE is N/A, compared to DBGR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DBGR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HFXE has a market cap of 8.41M. Regarding current trading prices, MDLOX is priced at $19.16, while HFXE trades at $19.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HFXE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HFXE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to HFXE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CNY has a market cap of 7.63M. Regarding current trading prices, MDLOX is priced at $19.16, while CNY trades at $44.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CNY's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CNY's ROE of +0.06%. Regarding short-term risk, MDLOX is less volatile compared to CNY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, WRND has a market cap of 7.35M. Regarding current trading prices, MDLOX is priced at $19.16, while WRND trades at $29.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas WRND's P/E ratio is 16.44. In terms of profitability, MDLOX's ROE is N/A, compared to WRND's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to WRND. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IRBA has a market cap of 7.29M. Regarding current trading prices, MDLOX is priced at $19.16, while IRBA trades at $9.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IRBA's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to IRBA's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IRBA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HFXJ has a market cap of 7.12M. Regarding current trading prices, MDLOX is priced at $19.16, while HFXJ trades at $20.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HFXJ's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HFXJ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to HFXJ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RYLG has a market cap of 7.03M. Regarding current trading prices, MDLOX is priced at $19.16, while RYLG trades at $20.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RYLG's P/E ratio is 16.18. In terms of profitability, MDLOX's ROE is N/A, compared to RYLG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RYLG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, XBUY has a market cap of 6.91M. Regarding current trading prices, MDLOX is priced at $19.16, while XBUY trades at $32.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas XBUY's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to XBUY's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to XBUY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, TPAY has a market cap of 6.91M. Regarding current trading prices, MDLOX is priced at $19.16, while TPAY trades at $25.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas TPAY's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to TPAY's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to TPAY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, BYOB has a market cap of 6.91M. Regarding current trading prices, MDLOX is priced at $19.16, while BYOB trades at $19.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas BYOB's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to BYOB's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to BYOB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, IXSE has a market cap of 6.78M. Regarding current trading prices, MDLOX is priced at $19.16, while IXSE trades at $33.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas IXSE's P/E ratio is 28.90. In terms of profitability, MDLOX's ROE is N/A, compared to IXSE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to IXSE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SDGA has a market cap of 6.76M. Regarding current trading prices, MDLOX is priced at $19.16, while SDGA trades at $22.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SDGA's P/E ratio is 15.15. In terms of profitability, MDLOX's ROE is N/A, compared to SDGA's ROE of N/A. Regarding short-term risk, MDLOX is less volatile compared to SDGA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, NTZG has a market cap of 6.67M. Regarding current trading prices, MDLOX is priced at $19.16, while NTZG trades at $32.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas NTZG's P/E ratio is 22.87. In terms of profitability, MDLOX's ROE is N/A, compared to NTZG's ROE of +0.00%. Regarding short-term risk, MDLOX and NTZG have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DIVD has a market cap of 6.55M. Regarding current trading prices, MDLOX is priced at $19.16, while DIVD trades at $34.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DIVD's P/E ratio is 16.25. In terms of profitability, MDLOX's ROE is N/A, compared to DIVD's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DIVD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CROP has a market cap of 6.46M. Regarding current trading prices, MDLOX is priced at $19.16, while CROP trades at $32.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CROP's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to CROP's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CROP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, ORG has a market cap of 6.37M. Regarding current trading prices, MDLOX is priced at $19.16, while ORG trades at $19.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas ORG's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to ORG's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to ORG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, JRNY has a market cap of 6.36M. Regarding current trading prices, MDLOX is priced at $19.16, while JRNY trades at $25.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas JRNY's P/E ratio is 29.93. In terms of profitability, MDLOX's ROE is N/A, compared to JRNY's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to JRNY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, EWJE has a market cap of 6.34M. Regarding current trading prices, MDLOX is priced at $19.16, while EWJE trades at $31.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas EWJE's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to EWJE's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to EWJE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CHIR has a market cap of 6.29M. Regarding current trading prices, MDLOX is priced at $19.16, while CHIR trades at $12.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CHIR's P/E ratio is 4.12. In terms of profitability, MDLOX's ROE is N/A, compared to CHIR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CHIR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, HEWP has a market cap of 6.02M. Regarding current trading prices, MDLOX is priced at $19.16, while HEWP trades at $17.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas HEWP's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to HEWP's ROE of +0.00%. Regarding short-term risk, MDLOX and HEWP have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, CN has a market cap of 5.95M. Regarding current trading prices, MDLOX is priced at $19.16, while CN trades at $23.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas CN's P/E ratio is 9.65. In terms of profitability, MDLOX's ROE is N/A, compared to CN's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to CN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, RJZ has a market cap of 5.89M. Regarding current trading prices, MDLOX is priced at $19.16, while RJZ trades at $9.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas RJZ's P/E ratio is N/A. In terms of profitability, MDLOX's ROE is N/A, compared to RJZ's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to RJZ. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FTAG has a market cap of 5.86M. Regarding current trading prices, MDLOX is priced at $19.16, while FTAG trades at $25.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FTAG's P/E ratio is 20.85. In terms of profitability, MDLOX's ROE is N/A, compared to FTAG's ROE of +0.00%. Regarding short-term risk, MDLOX and FTAG have similar daily volatility (0.00).

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, DWCR has a market cap of 5.73M. Regarding current trading prices, MDLOX is priced at $19.16, while DWCR trades at $29.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas DWCR's P/E ratio is 15.55. In terms of profitability, MDLOX's ROE is N/A, compared to DWCR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to DWCR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, FLFR has a market cap of 5.54M. Regarding current trading prices, MDLOX is priced at $19.16, while FLFR trades at $27.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas FLFR's P/E ratio is 15.29. In terms of profitability, MDLOX's ROE is N/A, compared to FLFR's ROE of +0.00%. Regarding short-term risk, MDLOX is less volatile compared to FLFR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.

MDLOX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLOX stands at 15.71B. In comparison, SOLCF has a market cap of 4.90M. Regarding current trading prices, MDLOX is priced at $19.16, while SOLCF trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLOX currently has a P/E ratio of N/A, whereas SOLCF's P/E ratio is -0.13. In terms of profitability, MDLOX's ROE is N/A, compared to SOLCF's ROE of +9.92%. Regarding short-term risk, MDLOX is less volatile compared to SOLCF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLOX.